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The tragedies of life are largely arterial. 
 
























Aortic dissection is a complex dynamic disease and is the commonest manifestation of the 
acute aortic syndrome. Outcomes for this disease have not changed significantly despite 
advances in therapy. Several negative prognostic indicators have been identified but these 
are generally morphological entities. It is likely that aortic haemodynamics in this pathological 
state are complex and more than likely contribute to morphological changes seen over time. 
This is of particular concern in patients who are deemed stable and yet go on to develop 
complications. A one size fits all strategy is unrealistic in this cohort of patients.  
There have been considerable advances in non-invasive diagnostic techniques and although 
CT is reliable, quick and readily available, MRI provides excellent anatomical detail and 
application of black blood techniques has the potential to provide vessel wall and therefore 
tear morphology. Additionally, MRI delivers dynamic functional data. Coupled with 
computational fluid dynamics there is significant potential to develop a method of non-
invasively assessing the haemodynamics in aortic dissection.  
The aorta is a complex organ that is subject to a variety of forces thereby undergoing 
deformation throughout the cardiac cycle. In the setting of a dissection with a fragile intimal 
flap the variation of motion of the flap can be significant. Dual phase imaging may have the 
potential to understand the dynamic variability in aortic motion and the deformation it 
experiences.  
In this work, four studies based on the aforementioned factors were undertaken with the aim 
of highlighting the need for individualised management strategy in aortic dissection. 
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Aortic dissection is a major cardiovascular emergency and the commonest aortic 
catastrophe. A tear in the intima leads to formation of a false lumen between the intima and 
the media. This false lumen is an alternative channel for blood flow and can lead to several 
fatal complications such as end organ ischaemia, aortic rupture and cardiac tamponade. 
Management of this disease depends on the morphology of the dissection, in particular, 
whether it involves the ascending (Stanford Type A, Debakey I and II) or descending aorta 
(Stanford Type B or Debakey Type III) as well as the presence of associated complications 
including end organ ischaemic events, rapid aortic growth and aortic rupture. 
Emergency surgery is the treatment of choice for dissection involving the ascending aorta 
although not every patient may be a candidate for surgery in view of pre-existing co-
morbidities or a moribund preoperative state. Patients with dissection involving the 
descending aorta are generally managed with strict pharmacological blood pressure control, 
although surgery becomes necessary in those who develop complications.  
Outcomes of patients with chronic, non-surgically treated descending aortic dissection (as 
well as surgically repaired ascending aortic dissection with a residual dissection in the 
descending aorta) are variable, with more than 1 in 4 patients dead at 5 years from their 
original presentation. Predictors of outcomes are therefore needed to improve the prognosis 
in this population. Several negative prognostic factors are already known and one of these is 
false lumen expansion leading to aortic rupture. Haemodynamics within the false lumen may 
hold the answer to why some patients remain stable and whilst others do not. A non-invasive 
method of determining these haemodynamic parameters will provide important insight into 
this complex disease and a greater understanding of how to best manage it at an early stage 
and in the long term. 





Aortic dissection: The cl inical problem  
 
2.1 Clinical Background 
 
2 . 1 . 1  H i s t o r y  
 
Acute aortic dissection is a life threatening medical emergency and the commonest 
manifestation of the acute aortic syndrome, an umbrella term for those conditions that carry a 
real and inherent risk of aortic rupture, including penetrating aortic ulcer, intramural 
haematoma and aortic dissection. Of these conditions, aortic dissection is the commonest, 
(62-88%) followed by intramural haematoma (10-30%) and penetrating ulcer (2-8%). (1)  
Aortic dissection is a disease of the 
media. Cystic medical necrosis 
weakens the aortic integrity with a 
tear developing in the aortic intima 
and formation of a false lumen, 
Figure 1. Frank Nichols, physician 
to the then King of England, 
George II, made the first 
description of acute aortic dissection 
in 1760. On the morning of October 
25th 1760, following a drink of hot chocolate, the 76-year-old King as per usual, retired to the 
toilet. Several minutes later, his valet heard a noise louder than ‘the royal wind’ and rushed 
into the toilet to discover the King lying face down on the floor, with a laceration to the 
forehead. After laying the King onto his bed, his daughter Amelia was sent for and it was she, 
who discovered that he was dead. Dr Nichols was instructed to embalm the royal corpse. 
During this process he made the discovery of a tear in the right ventricle and a transverse 
FIGURE 1 AN INTIMAL TEAR RESULTS IN A TRUE AND 
FALSE LUMEN FOR BLOOD FLOW (2) 
 




fissure in the inner layer of the aorta which had allowed blood to leak out into the external 
layer of the aorta, and eventually into the pericardium, causing tamponade (3). However, it 
was not till 1954 when the all-star team of Denton Cooley and Michael Debakey in Houston, 
Texas performed the first successful case of repair of a descending aortic dissection (4,5) 
 




The human aorta, consisting of the ascending aorta, arch and descending aorta is a complex 
structure complicated by obliquity and asymmetry. The ascending aorta has two portions; the 
aortic root or a lower portion that extends from the aortic valve to the sinotubular junction, 
including the aortic annulus and sinuses of Valsalva and an upper part that extends from the 
sinotubular junction to the origin of the innominate artery. The origin of the innominate artery 
is the landmark for the beginning of the aortic arch (Figure 2).  
The aortic root provides support to the aortic valve leaflets as well as the sinuses of Valsalva 
from where the coronary arteries originate. The majority of dissections and intramural 
haematomas of the ascending aorta originate from within a few centimetres of the aortic 
valve.  
The descending aorta begins just distal to the origin of the left subclavian artery at the aortic 
isthmus. The isthmus is particularly vulnerable to deceleration forces during trauma as here 
the relatively mobile ascending aorta and arch become relatively fixed to the thoracic cage. 
As a result, most descending aortic dissections and intramural hematomas have their origin 
just distal to the left subclavian artery. 
 





FIGURE 2 SEGMENTS OF THE AORTA. THE AORTIC ROOT EXTENDS FROM THE 
AORTIC ANNULUS TO THE SINOTUBULAR JUNCTION. THE ASCENDING AORTA 
COMMENCES AT THE SINOTUBULAR JUNCTION AND EXTENDS TO THE ORIGIN OF 
THE INNOMINATE ARTERY. THE ARCH OF THE AORTA EXTENDS FROM THE 
ORIGIN OF THE INNOMINATE ARTERY TO THE LEFT SUBCLAVIAN ARTERY. THE 
DESCENDING AORTA EXTENDS FROM THE LEFT SUBCLAVIAN TO THE 
DIAPHRAGMATIC HIATUS WHERE IT CROSSES TO BECOME THE ABDOMINAL 
AORTA 




Figure 3 shows the structure of the aorta consists of three distinct anatomic layers; the 
innermost tunica intima, the muscular media and the outer layer, the tunica externa or 
adventitia.  
The intima is a metabolically active mono-layered structure consisting of endothelial cells, 
with a loose connective tissue base that allows movement of the intima relative to the 
muscular media accommodating changes in the cardiac cycle. In contrast, the media 
consists of many lamellar elastic fibres, interposed with collagenous fibres and smooth 
muscle. These anatomic features allow for distensibility, stretch and aortic integrity as well as 
modulation of vascular tone in response to shear stresses induced by the blood flow. The 
 
  
FIGURE 3 COMPONENTS OF THE ARTERIAL WALL (6). THE MONOLAYERED INTIMA IS A THIN 
BASAL MEMBRANE WITH A SUBENDOTHELIAL LAYER, THE THICKNESS OF WHICH VARIES WITH 
AGE AND DISEASE. THE MEDIA IS COMPOSED OF SMOOTH MUSCLE CELLS, A NETWORK OF 
ELASTIC AND COLLAGEN FIBRILS AND ELASTIC LAMINAE WHICH SEPARATE THE MEDIA INTO A 
NUMBER OF FIBRE-REINFORCED LAYERS. THE ADVENTITIA IS THE OUTERMOST LAYER AND 
PRIMARILY CONSISTS OF THICK BUNDLES OF COLLAGEN FIBRILS. 
 




outermost adventitia is a tough layer of collagen and connective tissue that enhances overall 
aortic integrity. The dominant component is elastin in the thoracic aorta and collagen in the 
descending aorta. 
Aortic dissection is primarily a disease of the aortic media, where cystic necrosis leads to 
compromise in the aortic integrity. Eventually, a tear develops in the intima, allowing a new 
channel for blood flow, the false lumen, to form between the aortic media and intima. Often 
pressurized, the false lumen can propagate proximally towards the aortic valve, leading to 
acute aortic insufficiency, coronary artery compromise and even aortic rupture. Conversely, it 
may propagate distally, affecting the branches of the thoracic as well as the abdominal aorta 
along the way, leading to ischaemic cerebral, visceral or limb complications. 
Other manifestations of the acute aortic syndrome, such as intramural haematoma and 
penetrating aortic ulcer have a similar pathogenesis, presentation and natural history to 
acute dissection. Intramural hematoma develops from haemorrhage within the aortic wall 
(ruptured vasa vasora), commonly within the descending thoracic aorta. Although lacking a 
demonstrable tear, it is nonetheless thought to be a precursor to dissection, with a similar 
prognosis. Penetrating ulcers usually occur in elderly patients within a heavily atherosclerotic 
descending aorta, and can be a precursor to dissection. Generally, large (greater than 3 cm 
in diameter) and symptomatic ulcers should be managed surgically. (4)  
 
 





FIGURE 4 MANIFESTATIONS OF THE ACUTE AORTIC SYNDROME. TL= TRUE LUMEN, FL= FALSE 




The incidence of acute aortic dissection is 4-10 per 100 000 in the UK and the USA, although 
since this is not a reportable disease and fewer autopsies are being performed, actual 
numbers may in fact be much higher.    
2.1.2.3 Aetiology 
 
Aortic dissection is a complex disease with a multifactorial aetiology and any weakening of 
aortic structure may predispose the patient to dissection.  
Age: Aortic dissection is commoner in patients between 60-75 years (40%) than in younger 
patients or those older than 75 years. The aetiology in younger patients tends to reflect aorto-
vascular or connective tissue disease in contrast to atherosclerosis that affects the older 
population.  (8) 
Sex:  Prevalence studies have demonstrated a male predilection of 3:1.  
Hypertension:  Hypertension is the most important predisposing factor for aortic dissection 
affecting up to 70% of patients. Data from The International Registry of Acute Aortic 




Dissections (IRAD) has identified a history of hypertension as being an independent risk 
factor for Type A aortic dissection in aortic diameters less than 5.5cm. (9)  
Systolic hypertension exacerbates the haemodynamic forces acting upon the mobile 
ascending and the relative fixed aortic arch and descending aorta thereby affecting aortic 
integrity in the acute setting. A study by Juvonen et al demonstrated that higher mean arterial 
and diastolic pressures were independent risk factors for the development of aortic rupture in 
chronic, medically treated Type B dissection. (10) 
Genetic predisposition: A number of genetic connective tissue disorders have been linked to 
aortic dissection. Although these form a smaller subset of the affected patient population, 
they make up the majority of younger patients (< 40 years) presenting with dissection. The 
incidence of acute aortic dissection depends on the genetic variant present. 
a. Marfan syndrome: Marfan syndrome is the commonest of all connective tissue 
disorders, with an estimated incidence of 1 in 5000 to 2-3 in 10 000. It was first 
described by the French physician Bernard Marfan in 1896 and occurs as a result of 
a variety of missense mutations on chromosome 15. These mutations affect the 
gene encoding for fibrillin-1, an elastin-matrix glycoprotein essential for the formation 
of microfibrils or elastic fibres vital for connective tissue function (11). Transmission 
is in an autosomal dominant fashion with complete penetrance. A myriad of clinical 
problems can occur with this disease, of which cardiac, musculoskeletal and ocular 
complications are the commonest. Approximately 70% of patients with Marfan 
syndrome develop thoracic aortic dissection.  
 
b. Loeys-Dietz syndrome:  Loeys-Dietz syndrome was first described in 2005. It is an 
autosomal dominant disorder caused by mutations in the genes encoding the 
transforming growth factor beta receptor (TGFβR) (12). The main characteristics of 
Loeys-Dietz syndrome include arterial tortuosity, especially affecting the head and 
neck vessels, hypertelorism, a bifid uvula, and aneurysm formation, most commonly 




affecting the aortic root. Some 30% of patients with Loeys-Dietz syndrome develop 
thoracic aortic dissection.  (8)  
 
c. Ehlers-Danlos syndrome: Ehlers-Danlos syndrome encompasses a heterogeneous 
group of inherited connective tissue disorders characterised by joint hypermobility, 
cutaneous fragility and hyperextensibility (13). In the United Sates, the prevalence of 
this condition is approximately 1 in 400 000. The collagen defect has only been 
identified in 6 of the 11 types Ehlers-Danlos syndrome. 
 
d. Non-syndromic mutations in other genes (MYH11 and ACTA2) and single nucleotide 
polymorphism, in MMP3 and MMP9 have also been linked to the development of 
aortic dissection.  
 
Congenital cardiac anomalies: A bicuspid aortic valve (BAV) is the commonest inherited 
congenital cardiac anomaly, affecting up to 1-2% of the population and is responsible for the 
majority of cases of aortic stenosis under the age of 60 years (14). A co-inherited defect in 
the aortic media leads to enhanced apoptosis resulting in its weakening and subsequent 
dilatation. Patients with bicuspid aortic valve are at 5-18 times the risk of developing aortic 
dissection. 
Iatrogenic causes: Although rare, aortic dissection is thought to occur in up to 5% of cardiac 
surgical procedures (in particular aortic valve surgery) as well as in percutaneous 
revascularisation interventions. (15) 
Inflammatory conditions: Inflammatory conditions affecting the aorta (and other arteries) 
include Takayasu’s arteritis, giant cell arteritis, rheumatoid arthritis and syphilitic aortitis. 
Subsequent weakening and dilatation of the aorta can cause dissection. 
 




Miscellaneous causes: Any acute sustained increase in arterial blood pressure can lead to 
aortic dissection. Systolic blood pressure surges of up to 300mmHg have been well 
documented in weight lifters, and these are an ‘at risk’ group (16). In addition, sudden acute 
hypertension caused by emotional stressors has also been implicated. Finally, cocaine has 
also been known to result in aortic dissection.  
 
2.2 Classif ication 
 
Disease classification is an essential component of risk stratification and patient 
management. Classification of aortic dissection is important and helps to differentiate 
between cases requiring prompt surgical intervention and those, which can be managed 
conservatively.  
Acute aortic dissection is classified either by the location of the primary intimal tear or the 
involvement of the ascending aorta. (Figure 5) The Debakey (I, II, III) classification was 
devised in 1965 and is based on the origin of the primary intimal tear. (5) The Stanford 
classification method was proposed in 1970 and sought to simplify the original Debakey 
classification in that the location of the intimal tear did not contribute to the classification. (17) 
 





FIGURE 5 CLASSIFICATION OF AORTIC DISSECTION, DEBAKEY AND STANFORD. IN 
STANFORD TYPE A THE ASCENDING AORTA IS INVOLVED IN THE DISSECTION. IN 
STANFORD TYPE B THE DESCENDING AORTA IS INVOLVED. IN THE DEBAKEY SYSTEM 
THE LOCATION OF THE TEAR IS IMPORTANT, AND IN TYPE I AND II THE TEAR IS 
LOCATED IN THE ASCENDING AORTA WHEREAS IN TYPE III THE TEAR IS IN THE 
DESCENDING AORTA.  
 
 
In Debakey Type I and II aortic dissection, the intimal tear is located in the ascending aorta, 
whereas in Type III it is located distal to the left subclavian artery. (5,17)  
By contrast, in the Stanford system, the origin of the tear does not matter and instead any 
involvement of the ascending aorta classifies the dissection as Type A whereas its non-
involvement classifies it as Type B. Typically in Debakey Type I and II subtypes, the 
dissection originates in the ascending aorta and propagates distally whereas in Type III the 
dissection originates in the descending thoracic aorta, distal to the left subclavian artery and 
extends distally, or rarely proximally and retrograde into the arch and ascending aorta 
(17,18).  
De Bakey Type I
Stanford  A    
De Bakey Type II
Stanford  A    
De Bakey Type III

















Based on these factors, it is a given that Stanford Type A dissection and Debakey Type I and 
II, by virtue of involving the ascending aorta require surgical intervention to prevent aortic 
rupture whereas Type B and Type III can be managed conservatively unless complications 
ensue.  
Dissection involving the arch is a controversial area. As management of these generally 
tends to be pharmacological, without surgical intervention, many recommend that this entity 





















The classical presentation for aortic dissection is a patient with acute, tearing, central chest 
pain radiating to the intra-scapular region. Other presenting features may include signs of 
acute left ventricular failure from aortic insufficiency, ischaemic manifestations from 
involvement of any of the branches of the aorta such as coronary compromise leading to 
acute myocardial infarction, stroke from extension into the supra-aortic branches, mesenteric 
infraction if the infra-diaphragmatic aorta is involved and death from aortic rupture or 
tamponade. 
 Neurological deficit has been reported in up to 17% of cases with Type A aortic (TAAD) 
dissection, and acute aortic regurgitation and unequal peripheral pulses in up to 32% of 
presenting cases. Other clinical features may include hypertension, usually in Type B 
dissection (TBAD) and hypotension in up to 25% of TAAD cases. Silent dissection without 
















A prompt diagnosis is crucial. Any history of central chest pain is, in the first instance 
investigated with an ECG and biochemical myocardial enzyme testing to exclude myocardial 
infarction. A chest radiograph is performed to rule out pleural or pulmonary diseases. 
Commonly now, a triple rule-out test in the form of an ECG-gated computed tomography 
angiogram (CTA) is performed upon presentation. This effectively images the pulmonary and 
coronary circulation in addition to the aorta. In doing so, this method excludes catastrophic 
causes of chest pain originating from these sites including myocardial infarction, pulmonary 
embolus and aortic dissection. (20). Quite often patients may undergo transthoracic 
echocardiography, although this is only really effective in imaging the first few centimetres of 
the ascending aorta in a patient with good echo windows.  
Although a dissection flap may not be evident, a false lumen, a dilated aorta and aortic 
insufficiency may be seen in these cases. Transoesophageal echocardiography (TOE) 
provides excellent views of the ascending, arch and proximal descending aorta although this 
is not routinely performed in the acute setting due to the potential adverse haemodynamic 
effects from the stress of the procedure. 
TOE does have a role in the perioperative setting to delineate flap anatomy and the 
functional state of the aortic valve. Figure 6 shows the perioperative TOE images from a 
patient with acute TAAD and Figure 7 shows the CT images in the same situation.  
 





FIGURE 6 TOE IMAGES FROM A PATIENT WITH ACUTE TAAD. YELLOW ARROW INDICATES 




               FIGURE 7 CT ANGIOGRAM (A&B) IMAGES FROM A PATIENT WITH ACUTE TAAD. YELLOW ARROW       










2.5 Clinical Management 
  
Immediate treatment measures once a diagnosis of aortic dissection is made include prompt 
resuscitation and aggressive blood pressure control (if hypertension is present). The aim is to 
maintain the systolic blood pressure lower than 100mmHg with the use of beta-blockade, and 
if required, vasodilators. Once haemodynamic stability is achieved, the patient is referred to a 
specialist team for optimal further management. Stanford TAAD requires prompt surgery, to 
treat acute heart failure from valvular insufficiency and prevent death from rupture and 
tamponade, whereas Stanford TBAD unless complicated by rapid growth, rupture or organ 
ischaemia can be managed conservatively, with aggressive anti-hypertensive agents. 
 
2 . 5 . 1  M a n a g e m e n t  o f  h y p e r t e n s i o n  
 
Normotension is essential in this subgroup of patients as it aims to prevent additional 
shearing forces on the aortic wall, which propagate the dissection further. Intravenous beta-
blockade is a first line therapy (labetalol, esmolol), titrated to maintain the systolic blood 
pressure below 100mmHg and a target heart rate between 60-80bpm. A fine balance exists 
between normotension and hypotension and bradycardia caused by the beta blockade. It is 
vital to maintain adequate cardiac output and tissue perfusion. Close monitoring of end organ 
perfusion by means of hourly urine output documentation is essential. In general, 
vasodilators such as glyceryl trinitrate (GTN) and isosorbide dinitrate (Isoket) are avoided as 
first line agents, and instead are added once beta blockade therapy has been established. 
The reflex tachycardia caused by dilating agents as well as the increase in pulse pressure 
can cause a sudden increase in the shear force on the aorta due to the fast rate of change of 
pressure (Δp/Δt where p= pressure and t= time), thereby potentiating tear propagation. 
Conversely, beta-blockers decrease the pulse pressure and therefore the Δp/Δt along with 
lowering the heart rate. Calcium channel antagonists can also be used but are 
contraindicated in patients with a history of second or third degree heart block.  




2 . 5 . 2  S u r g i c a l  m a n a g e m e n t  o f  a s c e n d i n g  a o r t i c  
d i s s e c t i o n  
 
The mortality from acute TAAD is in the order of 1% per hour. (21). Urgent surgery is 
recommended for patients with acute TAAD, although not all patients are suitable candidates 
for a major operative procedure. Following transfer to the operating room, under general 
anaesthesia with endotracheal intubation and ventilation, preparations are made for 
cardiopulmonary bypass. 
Circulatory control and bypass can be achieved via median sternotomy and central aortic 
access under TOE guidance to ensure cannulation of the true lumen or via peripheral 
cannulation (femoral arterial and venous or axillary arterial cannulation. 
Benefits of peripheral cannulation include control of the circulation prior to entering the chest, 
and risk of aortic rupture without central arterial access. Axillary cannulation allows for 
antegrade pump flow and selective antegrade cerebral perfusion should it be desired, during 
periods of hypothermic circulatory arrest. 
Femoral cannulation although easier in practice due to the widespread familiarity with the 
anatomy of this region and superficial location of the artery may be complicated by 
retrograde extension of the dissection, or high arterial line pressures and poor flow in the 
case of an extensive thoracic and abdominal extension of the dissection.  In either case, 
although surgical practices vary, a 10mm woven vascular graft is sewn onto the desired 
peripheral artery and connected onto the arterial line from the cardiopulmonary bypass 
circuit.   
General considerations for surgery for ascending aortic dissection are identification and 
resection of the primary tear, stabilisation of the aortic wall (using adjuncts such as glue, 
Bioglue, CryoLife, GA, USA) prevention of aortic rupture, protection of end-organs (in 
particular the brain) and correction of malperfusion syndromes by ensuring resection of the 
primary ascending aortic tear (21). 






















FIGURE 8 OPERATIONS FOR TAAD. A) REPLACEMENT OF 
THE SUPRA-COMMISSURAL ASCENDING AORTA. B) HEMI-
ARCH REPLACEMENT. C) ARCH REPLACEMENT. D) 
TRIFURCATED GRAFT AND ARCH DEBRANCHMENT (21) 




A variety of cannulation options exist but essentially venous drainage occurs from the right 
atrium, with arterial return either into the distal aorta (true lumen cannulation is directed via 
TOE using a Seldinger technique) or via the femoral or axillary artery as described above. 
Hypothermia is initiated once the patient is on cardiopulmonary bypass to allow for an 
‘open’ distal anastomosis without an aortic cross clamp, under deep hypothermic circulatory 
arrest. Under cardioplegic arrest the distal ascending aorta is inspected, looking specifically 
for the intimal tear.  
Aortic valvular function and anatomy should have been already assessed by perioperative 
TOE if time allows, as well as by visual inspection. Bioglue (CryoLife, GA, USA) or similar 
adjuncts are used to approximate and secure the true and false lumens and replacement of 
the ascending aorta is performed usually using a synthetic graft, although various additional 
procedures may also be required (valve repair/re-suspension/replacement/hemi-arch 














2 . 5 . 3  S u r g i c a l  m a n a g e m e n t  o f  d e s c e n d i n g  a o r t i c  
d i s s e c t i o n  
 
The development of ischaemic complications, uncontrollable hypertension, on-going pain 
indicative of aortic growth and aneurysm formation as well as aortic rupture and are poor 











FIGURE 9 TEVAR AIMS TO SEAL OFF THE ENTRY TEAR AND PROMOTE 
AORTIC REMODELLING. (24) 
 
THE OBJECTIVE OF THE THORACIC STENT GRAFT IS TO OCCLUDE THE ENTRY 
TEAR, THEREBY SEALING THE FALSE LUMEN, PROMOTING THROMBOSIS ( 
 
Figure 9 This is associated with a more favourable outcome. (24,25) Current indications for 
thoracic endovascular aortic repair (TEVAR) include the presence of symptoms, aortic 
diameter greater than 5.5cm or a growth rate of over 1 cm per year. (26) 
In the multi-centre Investigation of Stent Grafts in patients with TBAD (INSTEAD), a 
prospective multicentre, European randomized trial, optimal medical therapy was compared 




with endovascular stent graft placement for stable TBADs. At one year, no significant all-
cause mortality was found. At five years however, TEVAR, in addition to medical treatment 
was associated with improved aorta-specific survival and delayed disease progression. 
(27,28) Results of the ongoing Acute Dissection: Stent graft or Best Medical Therapy 
(ADSORB study) which aim to compare best medial management with stent graft in acute 
uncomplicated patients with TBAD presenting less than 14 days after onset of symptoms will 

























The prognosis of untreated TAAD is extremely poor, with a mortality of 1% per hour. Fifty per 
cent of all patients are dead within the first 48 hours, and 75-90% within the first week. 
(21,30,31)  
Medically managed TAAD carries a mortality of 30-50% at 48 hours but of those who survive, 
the trajectory is different, with 1-year mortality rate of 12%. (31) In contrast, surgical mortality 
is between 15-20%, although this is lower at approximately 10-12% in high volume aortic 
centres.  
Acute TBAD may be complicated by visceral or limb ischaemia or aortic rupture. Mortality 
rates in this setting are much higher.  
In-hospital mortality rates according to the type of dissection and the relevant management 
are given in Table 1 and are illustrated by Kaplan Meier curves in Figure 10. Figure 11 
depicts the longer-term mortality rates for Type A and TBAD and Figure 12 compares the 
five-year survival for TBAD when managed conservatively versus endovascular intervention.  
Of note, up to 1-in-4 patients with Type B aortic dissection surviving hospital discharge are 
dead at 3 years. Factors responsible for this poor prognosis need to be sought and 











TABLE 1 MORTALITY RATES FOR AORTIC DISSECTION BY TYPE AND MANAGEMENT 
 Mortal i ty rates by management %  
Untreated Medical Open surgery TEVAR 
1 week 48h 1y 3y 30d    1y 3y 5y 30d 1y 
 


































































FIGURE 10 IN-HOSPITAL 
MORTALITY FOR 
MEDICALLY MANAGED AND SURGICALLY MANAGED AORTIC DISSECTION. MEDICALLY MANAGED 









FIGURE 11 A UNADJUSTED KAPLAN-MEIER SURVIVAL CURVE STRATIFIED BY IN-HOSPITAL 
MANAGEMENT FROM DATE OF HOSPITAL DISCHARGE IN PATIENTS WITH TAAD DISSECTION. (31) 
B. UNADJUSTED KAPLAN-MEIER SURVIVAL CURVE STRATIFIED BY IN-HOSPITAL MANAGEMENT OF 
PATIENTS WITH ACUTE TBAD WHO SURVIVE TO HOSPITAL DISCHARGE (32) 
 
 
FIGURE 12 FIVE-YEAR SURVIVAL RATES FOR MEDICALLY TREATED TBAD VERSUS 









2.7 Fate of the false lumen 
 
Failure to seal the false lumen successfully, either during surgery by failing to exclude the 
primary tear or by thrombosis over time in medically treated cases leads to on-going aortic 
expansion and potentially further complications. Several studies have indicated the 
importance of the fate of the false lumen in aortic dissection (33–39). Although blood 
pressure has been implicated in false lumen expansion, no study to date has 




Patients with chronic stable and repaired aortic dissection require careful and regular follow 
up in view of potential late complications including continued aortic dilatation and re-
dissection, in particular, in the case of the untreated distal aorta. Risk factors for these 
potential complications include untreated hypertension, a non-resected entry tear, a large 
initial aortic diameter, a patent false lumen and Marfan pathology. (34) Patients treated with 
endografts must also be monitored for potential future endoleaks.  
Based on local clinical protocols which may vary from unit to unit, patients are usually 
followed up with imaging at 3-month intervals in the first year, careful monitoring of their 
blood pressure at every visit and titration of their anti-hypertensive medication. Imaging of the 
aorta is necessary to monitor anatomical changes and magnetic resonance imaging (MRI) 
seems the best option given the avoidance of ionising radiation. Unfortunately, not all centres 
have access to MRI scanners and imaging with CT seems to be the commonest modality in 
use at present (26). Although phase-contrast MRI (PC-MRI) can provide blood velocity data, 
no modality has as of yet, provided other important physiological haemodynamic parameters 
such as pressure or wall shear stress.  
 




2.9 Clinical issues 
 
Aortic dissection represents a complex disease with a multifactorial aetiology and a variable 
prognosis. Although considerable work has been done and continues to be undertaken into 
this life threatening disorder, the mainstay of treatment and follow-up has not changed 
dramatically. This is reflected in the overall prognosis and outcomes from this challenging 
disease. Although dissection itself adds a separate dimension, the complexity of the aorta as 
an organ should not be forgotten. The movement of the aorta with respect to the cardiac 
cycle, the changes in diameter, area and other quantifiable dimensions is remarkable. The 
addition of such forces upon a fragile intimal flap must have a significant impact. (40,41) 
Although tear morphology is important in predicting prognosis and steering clinical 
management, it is in fact the resulting haemodynamics that determine the pathophysiology of 
dissection. (42,43) Several studies have demonstrated the importance of geometric 
considerations such as tear location, number and size in determining outcomes in this patient 
group. Weiss et al postulated that adverse haemodynamics, in particular, pressure gradients 
were responsible for higher rates of complicated dissections in patients with tears that were 
located on the concavity of the aortic arch (43). Other studies have demonstrated that larger 
tears lead to true lumen collapse and visceral ischaemia (44). Large tears can lead to 
pressure equalisation between the true and false lumens and the absence of exit tears can 
lead to a pressurized false lumen, which will be vulnerable to expansion. (39) 
The aim of any surgical intervention is to seal the false lumen and promote thrombosis. 
However, in cases where only partial thrombosis follows from an inadequate or incomplete 
surgical intervention, there is considerable risk of false lumen pressurization. Tsai et al. 
demonstrated that partial thrombosis occurs in up to a third of patients following TBAD and 
this is directly associated with a 2.7 fold increase in mortality compared to a patent false 
lumen. The hypothesis for this phenomenon is shown in Figure 13. (39)  
From these and other observations, it is likely that mechanical and haemodynamic conditions 
play a significant role in the propagation of aortic disection. Currently, the only possible 




method of determining false lumen pressure is invasively, with the use of a pressure catheter 
but the invasive nature of this procedure does not lend it self to routine use. In addition to 
pressure, wall shear stress (WSS) (which is intimately related to blood velocity) plays a 
significant role in aortic dissection. WSS is related to blood velocity and lower WSS leads to 
thrombosis. PC-MRI allows for measurement of blood velocity, although this is a time- 
averaged representation, therefore being susceptible to errors such as Maxwell terms, and 
eddy currents (45).  
At present, we lack sophisticated non-invasive methods that allow a detailed study of this 
dynamic disease. Computational modelling, imaging and simulation methods may allow for a 
comprehensive understanding of the complex flow and haemodynamic patterns that are 
seen in aortic dissection, on a case-by-case, individualised basis. (46) This will in turn allow 
for customised follow-up and management pathways for this complex sub-group of patients 
with the overall aim of improving outcomes.  












FIGURE 13 A PROPOSED MODEL OF THE PHYSIOLOGICAL CONSEQUENCES OF FALSE-LUMEN 
PATENCY OR THROMBOSIS, BASED ON HEMODYNAMIC STUDIES IN EX VIVO MODELS AND IN 
PATIENTS WITH TYPE B AORTIC DISSECTION. 
A. TBAD WITH PATENT PROXIMAL AND PATENT DISTAL RE-ENTRY TEARS IN THE ABSENCE OF 
THROMBUS. THE BLOOD-PRESSURE TRACING SHOWS SYSTOLIC, DIASTOLIC, AND MEAN 
ARTERIAL PRESSURES IN THE FALSE LUMEN SIMILAR TO THE PRESSURES IN THE TRUE 
LUMEN. 
B. TBAD WITH A PATENT ENTRY TEAR AND PARTIAL THROMBOSIS THAT OCCUPIES THE INNER 
CIRCUMFERENCE OF THE FALSE LUMEN AND OBSTRUCTS THE RE-ENTRY TEARS, FORMING A 
BLIND SAC. THE BLOOD-PRESSURE TRACING SHOWS DIASTOLIC AND MEAN ARTERIAL 
PRESSURES IN THE FALSE LUMEN THAT EXCEED THE PRESSURES SEEN IN A, WITH 
IDENTICAL PRESSURES IN THE TRUE LUMEN. 
C. TBAD WITH A FALSE LUMEN FILLED WITH THROMBUS AND NO LONGER COMMUNICATING 
WITH THE TRUE LUMEN. THE PRESSURE WITHIN THE FALSE LUMEN IS LIKELY TO BE LOW AND 
NON-PULSATILE. 
BP = BLOOD PRESSURE, MAP= MEAN ARTERIAL PRESSURE(39). 
 




Chapter 3  
3.1 Imaging Modalit ies in Aortic Dissection 
 
3 . 1 . 1  C h a l l e n g e s  
 
Imaging of the aorta has many challenges. The morphology of the aorta is complex, with the 
ascending aorta not being a truly vertical structure, thereby making it difficult to obtain 
accurate images. The normal aorta is dilated at the level of the sinuses and then has an 
indentation or waist that is approximately within 2-3mm of the annular size at the sinotubular 
junction. During imaging, identification of this waist or a loss of waist is important as this is an 
indication of future aortic related issues.  
The aortic arch is sharply curved giving an oblong contour on axial images and this can give 
misleading dimensions. The descending aorta at the level of the 12th thoracic vertebra 
becomes the abdominal aorta and in the elderly can curve quite acutely, again giving rise to 
non-circular images on axial planes. Figure 14 shows the normal CT appearances of the 
ascending aorta, with important landmarks used in clinical reporting. Note is made of the 









      FIGURE 14 CT IMAGE OF A NORMAL AORTA IN A 54 YEAR OLD MAN. THE DIFFERENT 
LINES REPRESENT THE LANDMARKS USED IN REPORTING A CLINICAL SCAN. BLACK SOLID 
LINE= AORTIC ROOT, WHITE SOLID LINE= SINUSES OF VALSALVA, BLACK DASHED LINE= 
SINOTUBULAR JUNCTION. WHITE DASHED LINE= MID ASCENDING AORTA. BLACK DOTTED 
LINE= DISTAL ASCENDING AORTA. (47) 
 
 
The risk of contrast-induced nephropathy is not to be underestimated when considering CT 
examination and neither is that of exposure to significant radiation. (48,49)  
Whilst MRI does not pose the same risk of radiation, the risk of gadolinium induced 
nephrogenic systemic fibrosis (NSF) in renal failure patients does exist. Additionally the lack 
of general availability in community hospitals does limit the use of this technique for routine 
clinical diagnosis. (50) 
Trans-thoracic (TTE) and TOE may not always be readily available in all settings. Certainly a 
negative TTE does not exclude a diagnosis of dissection, and although TOE is far superior in 
its diagnostic accuracy, it requires an experienced operator and oesophageal intubation in a 
potentially unstable patient.  




3 . 1 . 2  C o m p u t e d  T o m o g r a p h y  
 
Prompt and accurate diagnosis of the morphology and nature of the dissection and its 
associated complications is essential to allow for optimal management at a specialist centre.  
CT is the first line imaging modality in patients with a high probability of the acute aortic 
syndrome due to its fast acquisition speed, high spatial resolution. The IRAD registry 
reported its use in 74% of patients. (15) Unenhanced images are performed to provide 
information on mediastinal haemorrhage, intramural haematoma, pericardial effusions and 
impending rupture. (51). A multidetector CT (MDCT) allows for the simultaneous acquisition 
of data by various detector rows, unlike helical CT where only one detector is used allowing 
for a proportional decrease in scanner time, improved vascular opacification, with less 
contrast media, less aortic motion, and fewer breathing artefacts. Electrocardiography-gated 
(ECG) CT angiography is especially useful for avoiding motion artefacts that might prevent 
accurate assessment of the aortic root and the ascending aorta, particularly in aortic 
dissection with involvement of the coronary ostia. (52) ECG can be performed either 
retrospectively or prospectively. In prospective gating, images are usually acquired during 
late diastole, whereas in retrospective gating, images are acquired throughout the cardiac 
cycle. As a result, retrospective gating provides more comprehensive data than prospective 
gating, albeit at the expense of increased radiation exposure. (53) 
CT performs well as far as providing important information for the treating physician, 
including the tear location and extent of involvement in particular, of the ascending 
aortaFigure 15). (54) In addition, information about the branching vessels and their 
relationship to the true and false lumen are important especially for endovascular repair as is 
the involvement of the aortic arch and root if open surgery is being planned. Other important 
information includes the presence of a pericardial effusion, which may be an indicator of 
impending aortic rupture, involvement of the coronary ostia and visceral arterial involvement.  
Although a quick and accurate examination, CT is nonetheless associated with contrast 
induced nephropathy in those with renal impairment and carries a real radiation risk in young 




patients and those who require repeated follow-up examinations after the initial diagnostic 
scan.(48,49)  
With respect to follow up of patients with chronic dissection where intervention may be 
indicated for size criteria, the presence of substantial inter observer variability in aortic 
measurements is recognised. Studies have shown that there can be up to 2.8mm +/- 4.4mm 
difference in maximum aortic diameter measured between experienced radiologists, when 
using standardized protocols. This can be much higher at 4.0+/- 5.1mm when non-
standardized methods are used. (55) Although the introduction of standardised protocols for 
measurement, such as using fine callipers and measuring the largest diameter perpendicular 
to the aneurysm centreline decrease this variability, it is never truly eliminated. This is 
important to bear in mind when repeated scans in the same patient are undertaken and 
where size changes can mean the difference between intervention and conservative 
management. 
 
FIGURE 15 CT IMAGES FROM A PATIENT WITH ACUTE TAAD. THE RED ARROW INDICATES THE 
POSITION OF THE TRUE LUMEN, THE YELLOW ARROW INDICATES THE POSITION OF THE FALSE 








3 . 1 . 3  M a g n e t i c  R e s o n a n c e  I m a g i n g   
 
MRI is a highly sensitive and specific, non-invasive imaging modality. Unlike CT, MRI does 
not expose patients to ionizing radiation or potentially nephrotoxic iodinated contrast agents, 
making it an attractive option for patients who require repeated imaging. (56–58) There exists 
the risk of nephrogenic systemic fibrosis with gadolinium use in those with pre-existing renal 
impairment but this is rare. (50) Specific to the acute aortic syndrome, MRI is useful for 
detection of aortic valve and coronary artery involvement. Furthermore, MRI does not require 
contrast agents to visualize vessel anatomy including the vessel wall and intimal tears.  
MRI can provide morphological evaluation such as information on vessel wall, diameter 
lumen patency, wall characteristics, and relations to other anatomical structures. Additionally, 
and unlike CT, MRI can provide functional evaluation such as blood flow, velocity. (59) 
There are many different magnetic resonance angiography (MRA) techniques, which can 
include bright blood imaging, with or without contrast, and black blood imaging. The use of 
gadolinium based contrast agents (GBCA) has expanded the utility of MRA in aortic 
diseases. Contrast-enhanced MRA (CE-MRA) commonly uses a 3D gradient echo (3D-
GRE), allowing thin contiguous image slices to be obtained during a single breath-hold. After 
the intravenous injection of a bolus of GBCA, there is a T1-shortening of blood so that the 
blood appears bright regardless of flow patterns or velocities. The image quality of CE-MRA 
depends on the intra-arterial concentration of the GBCA. It follows therefore that the image 
timing following contrast injection is crucial. (60) Nonetheless, the timing of image acquisition 
is less critical than for CT as gadolinium has a wider window of visibility than iodine.  
Black blood imaging is particularly useful in aortic dissection, in which a signal void is created 
by flowing blood and the vessel wall and intimal flap are depicted with positive contrast. 
(Figure 16, Figure 17) This can delineate tear and intimal anatomy in dissection. (61,62) 
Black-blood techniques are used in combination with other imaging sequences most often 
CE-MRA and /or non-contrast enhanced “bright-blood” techniques. 






FIGURE 16 CE-MRA IN A PATIENT WITH CHRONIC TBAD. RED ARROW SHOWS THE POSITION 
OF THE TRUE LUMEN, GREEN ARROW SHOWS THE INTIMAL FLAP, YELLOW ARROW SHOWS THE 
FALSE LUMEN AND BLUE ARROW THE AREA OF THROMBUS. 
 





FIGURE 17 WITH BLACK BLOOD MRI TECHNIQUES THE VESSEL WALL APPEARS BRIGHT AND 
BLOOD BLACK. THIS ALLOWS FOR CLEARER VISUALIZATION OF VESSEL WALL PATHOLOGY. 
THESE IMAGES ARE FROM HEALTHY VOLUNTEERS. 
 
Usually, slow blood flow is the main challenge of black blood techniques as acquiring 
diagnostic images with sufficient blood signal suppression is required. Standard black-blood 
methods consist of a T1-weighted (2D) spin echo sequence acquired with multiple two-
dimensional slices to cover the whole aorta in an axial or sagittal view (63). To minimize 
image artefacts from respiratory motion, images are typically acquired during breath-holds. 
Although this technique allows for high in-plane spatial resolution in the order of 1-2 mm2, the 
slice thickness is typically in the order of 6-10 mm, which may prohibit the visualization of 
small tears in the intimal flap in the case of aortic dissection.  
Further disadvantages of this approach are slice-to-slice mis-registration due to poor 
reproducibility of breath-hold positions and image artefacts due to slow-flowing or stagnant 
blood. To address these limitations three-dimensional (3D) bright blood dynamic contrast 
enhanced MR angiography of the aorta can be performed, which allows for isotropic 
resolution and insensitivity to respiratory motion (if performed during a breath-hold) and 
blood flow artefacts. However, this technique provides bright blood contrast with only 




intermediate spatial resolution (2-4 mm3 isotropic voxel size) and requires the administration 
of potentially nephrotoxic contrast agents, which may be contraindicated in patients with poor 
renal function. To overcome the limitations of the 2D black-blood and 3D bright-blood 
approaches for imaging aortic dissection, 3D black-blood vessel wall imaging methods have 
been developed using T2-prepared Inversion Recovery (T2IR) or alternatively T2-prepared 
Phase Sensitive Inversion Recovery sequences (T2PSIR). (63,64) 
 
3.1.3.1 Sequences for black blood imaging for vessel wall 
analysis 
 
The pulse sequence diagram of the T2PSIR and T2IR pulse sequences used are shown in 
Figure 18. T2IR has previously been used for flow-independent peripheral angiography. 
However, a similar sequence design can be utilized to generate black-blood vessel wall 
images.(65)  
In both approaches, an inversion pulse is performed to null signal from blood to generate 
black-blood contrast. To improve contrast between blood and vessel wall, a T2 preparation 
pulse is performed prior to the inversion pulse (64). The T2 preparation effectively eliminates 
a large portion of the longitudinal magnetization (Mz) from the vessel wall, which has a short 
T2 relaxation time while retaining the Mz from blood, which has a long T2, thereby minimizing 
the effect of the subsequent inversion pulse on the vessel wall signal. In this sense, the 
recovery of the vessel wall Mz is accelerated compared to the blood Mz, which starts with a 
larger negative magnetization immediately after the inversion pulse.  
In a conventional inversion recovery sequence using magnitude reconstruction the polarity of 
Mz is unknown, which may lead to reduced contrast between the vessel wall and blood if the 
inversion time (TI) between the inversion pulse and image acquisition is not carefully 
optimized. Phase sensitive inversion recovery can be used to improve robustness and to limit 
the adverse effects of suboptimal TI as this method can be used to restore the Mz polarity 




during image reconstruction and generate optimal contrast between tissues. (66,67) This is 
achieved by introducing a second image acquisition in the subsequent cardiac cycle, (ACQ2 
in Figure 18) which is used as a reference image with positive polarity and allows for the 
determination of polarity in the first acquisition (ACQ1 in Figure 18). This technique has not 
been used in aortic dissection before. 
 
 
FIGURE 18 T2PSIR AND T2IR SEQUENCES. TO MINIMIZE FLOW ARTEFACTS ORIGINATING 
FLOWING BLOOD DURING THE PERFORMANCE OF THE T2PREP THIS PRE-PULSE IS PERFORMED 
IN EARLY SYSTOLE IMMEDIATELY AFTER R-WAVE DETECTION. THE INVERSION TIME IS 
DETERMINED SUCH THAT BLOOD SIGNAL IS NULLED FOR T2IR WHILE FOR T2PSIR BLOOD 








3.1.3.2 Dual phase MRI imaging 
 
Image acquisition in MRI is usually performed in the diastolic phase of the cardiac cycle as 
there is a relatively low flow in this state. However to study aortic motion, data image 
acquired in both systole and diastole would be ideal as this would allow for an evaluation of 
aortic motion in the normal and abnormal aorta. This form of imaging would seem potentially 
more realistic given that the aorta is a complex dynamic entity.  
 
3 . 1 . 4 .  E c h o c a r d i o g r a p h y  
 
Echocardiography uses transthoracic or trans-oesophageal probes that emit ultrasound 
waves directed at cardiac structures. The returning signals are then received by the emitting 
probes and are then reconstructed to produce images of the heart. Echo probes also perform 
Doppler which measures the frequency shift of returning ultrasound waves to determine the 
speed and direction of moving blood in the heart.  
TTE is a good clinical tool to measure proximal parts of the ascending aorta, and is useful in 
the follow up of proximal aortic diseases such as aortic aneurysms. Aortic root diameters are 
best visualised using the long-axis views and the right parasternal view affords the best 
estimation of the true ascending aortic size. The aortic arch and supra-aortic vessels are best 
visualised in the suprasternal view. TTE has a sensitivity of 78-100% for TAADs and 31-55% 
for TBADs. (57) 
Trans-oesophageal echocardiography benefits from the proximity of the oesophagus to the 
aorta, allowing for high-resolution aortic imaging (Figure 19). Views of the ascending aorta, 
root and valve are best appreciated in the long axis (120-150°) and short axis views (30-60°) 
A blind spot due to the overlying trachea and right main bronchus exists around a short 
segment of the distal ascending aorta making useful interpretation of this region difficult. The 
descending aorta on the other hand is well visualised from the left subclavian to the coeliac 




trunk as is the aortic arch. TOE overall has a positive predictive value of 89% and a negative 




FIGURE 19 TOE LONG AXIS VIEW OF THE AORTIC ROOT SHOWING THE INTIMAL FLAP 
(YELLOW ARROW) AND TRUE AND FALSE LUMENS (TL, FL). LVOT = LEFT VENTRICULAR 















4.1 Computational Fluid Dynamics and 
Simulation 
 
With the advent of sophisticated 3-D imaging modalities, in particular, MRI, computational 
methods have moved forward from initial applications in idealised vascular models to patient 
specific anatomically and physiologically appropriate models. The use of image based 
modelling tools to investigate cardiovascular disease, in particular in the carotid, coronary 
and cerebral circulations dates back to the 1990s. (70–74) Since then patient specific 
applications have been developed for example, to predict the risk of rupture in aortic 
aneurysms. (75) 
The workflow needed to develop a patient specific model begins with the construction of an 
anatomically accurate geometry from imaging data, which can be in the form of CT, MRI or 
even ultrasonography. Next, physiological data such blood velocity and pressure are 
obtained from ultrasound, PC-MRI or invasive pressure monitoring, for example during a 
cardiac catheter. Boundary conditions both upstream and downstream are then applied, to 
represent the heart pump and the distal systemic circulation. Next, a mesh generator is used 
to discretize the constructed geometry and finally, the incompressible Navier-Stokes 
equations relating to blood flow are solved. The end result is physiological information 
relating to a patient, and includes important data as related to cardiovascular system such as 
blood pressure and wall shear stress, Figure 20. 





FIGURE 20 A. PATIENT-SPECIFIC ASCENDING AORTIC FLOW WAVEFORM MEASURED BY PC-MRI 
IS MAPPED TO THE INFLOW FACE OF THE CAD MODEL. A 3-ELEMENT WINDKESSEL MODEL WITH 
A PROXIMAL RESISTANCE (RP), CAPACITANCE (C), DISTAL RESISTANCE (RD) BOUNDARY 
CONDITION IS USED TO REPRESENT THE RESISTANCE AND COMPLIANCE OF THE VASCULATURE 
DOWNSTREAM OF EACH OUTLET. B. HAEMODYNAMIC RESULTS FROM CFD IN A PATIENT WITH 
AORTIC DISSECTION. FIGURES REPRESENT EARLY SYSTOLE MAPS OF BLOOD VELOCITY (LEFT) 
BLOOD PRESSURE (CENTRE) AND WALL SHEAR STRESS (RIGHT).  
 
 
4 . 1 . 1  C F D  i n  d i s s e c t i o n  s t u d i e s  
 
Several studies have investigated blood flow analysis in complex aortic geometries including 
aortic dissection and coarctation of the aorta. These have all shown the utility of CFD to 
investigate intra-aortic haemodynamic techniques in what may otherwise be an extremely 
challenging case.  
Karmonik et al have carried out several studies investigating the complex intra-aortic 
haemodynamics in aortic dissection. These include understanding the effects of occluded 
and patent intimal tears, haemodynamic changes in the aorta pre and post TEVAR and a 
comparison of aortic haemodynamics in a healthy and dissected aorta. (76–78). Rudenick et 
al investigated the agreement of haemodynamics between a computational model of a 
dissected aorta with that of an idealised model. These showed good agreement. (79) The 




main limiting factors in the majority of these studies have been the assumptions made to 
determine inflow and outflow boundary conditions. Many studies use flow data from healthy 
individuals and apply them to pathologic cases such as dissection, which is not ideal, given 
the complex anatomical changes and likely resulting haemodynamics in aortic dissection. 
(80,81) 
Although this limitation itself underpins the technical and practical difficulties in obtaining real 
time pressure and flow data from this select group of patients, it highlights the potential 
inaccuracies in the final model and resulting simulations developed. Patients with acute or 
chronic aortic dissection represent abnormal aortic haemodynamics and likely abnormal 
vascular structure throughout the body. In a bid to control hypertension, itself a driving force 
increasing wall shear stress and thereby propagating the intimal tear distally or proximally, 
beta-blockers are routinely prescribed to these patients in the acute setting and other agents 
such as aldosterone II antagonist in the chronic patient. These itself cause significant 
changes to the aortic haemodynamics, reducing wall shear stress and additionally cardiac 
workload. It is therefore quite apparent that applying normal human flow data to these 
complex patients will overestimate flow conditions. Additionally, some studies have applied 
pressure data from normal subjects or assumed zero pressure conditions, which again 
represent the same afore mentioned problems.  
To this end, Dillon-Murphy et al have shown the application of patient specific flow data from 
2D PC-MRI to inform an accurate model of aortic dissection and used tuned lumped-
parameter Windkessel models to represent accurately the resistance and compliance of the 
peripheral vasculature. (82) This study showed local areas of increased blood velocity, 
pressure and wall shear stress around the area of the entry tear. Additionally, an increase in 
cardiac workload with the onset of dissection was seen, up to a factor of 14% when 
compared to a normal aorta.  
This study also highlighted the difficulties in accurately identifying secondary tears from CT 
data which itself can be of limited quality. The investigators went on to study the impact of 




fewer tears compared to many tears in a dissected aorta and showed that the presence of 













































This work is structured around the following aims: 
 
1. Investigate the potential utility of non-invasive haemodynamics (such as blood 
velocity, pressure, and pulse pressure) derived via image-based modelling and 
compare this to invasive pressure readings taken at the time of TEVAR in recruited 
patients with chronic TBAD. 
 
2. To use this novel non-invasive method of evaluating false lumen haemodynamics to 
follow-up patients and determine if indeed abnormal false lumen haemodynamics 
contribute to aortic growth and therefore poorer outcomes.  
 
3. To investigate the efficacy and utility of two black blood (vessel wall) MRI sequences 
to image the aortic wall, with the aim of detailed visualisation of the dissected intimal 
flap and tear location. 
 
4. To study the variation in aortic motion during the cardiac cycle using dual phase MRI 
imaging and to use this method to study the variation in aortic motion and of the 










Chapter 6  
 




This study was divided into four parts.  
6 . 1 . 1  V a l i d a t i o n  s t u d y  
 
The first part was a validation study whereby invasive pressure recordings taken at the time 
of TEVAR were compared to non-invasive pressure estimates from preoperative imaging 
(PC-MRI) and simulation models. All adult patients (18-80 years) admitted with a diagnosis of 
Type B (acute and chronic) aortic dissection and surgically repaired TAAD with a residual, 
untreated Type B component were candidates for this study. Patients with chronic renal 
failure and those with other contraindications to MRI scanning were excluded.  
Patients with acute TBAD were approached on the wards and a patient information leaflet 
pertaining to the study was provided (Appendix 1). This explained the course of the 
investigation and allocation into the invasive arm if surgical intervention was contemplated 
and the non-invasive arm if conservative management was planned. In both circumstances a 
detailed pre-intervention (if any was planned) MRI scan was performed if the patient’s clinical 
condition was deemed stable.  
Chronic stable patients who were already in a clinical follow up program were contacted by 
means of an invitation letter and were given details and methods of indicating interest in 
participation. A total of 4 patients were recruited into this arm of the study.  
 
 




6 . 1 . 2  F o l l o w - u p  s t u d y  
 
In the second part of the study involving chronic stable patients, false lumen haemodynamics 
were assessed entirely non-invasively using MRI and simulation. A total of four patients were 
recruited into this arm, three with a one-year follow up. The last patient was recruited late into 
the study and only underwent a single scan. All patients were recruited following an invitation 
letter and all patients provided written consent to participate in the study. 
 
6 . 1 . 3  B l a c k  b l o o d  s t u d y  
 
A third study was conducted to evaluate the utility of new black blood sequences in imaging 
of aortic dissection, to help delineate tear anatomy and morphology. Eleven healthy 
volunteers and two patients with a Type B component in a previously repaired TAAD setting 
were included. All subjects provided written consent for this study.  
 
6 . 1 . 4  D u a l  p h a s e  s t u d y  
 
In the fourth and final part, a dual phase MRI study with imaging acquisition in systole and 
diastole was conducted to investigate aortic motion and strain throughout the cardiac cycle.  
Here 5 healthy volunteers and 2 patients with a residual Type B component were included. 
All subjects provided written consent for this study.  
 
6.2 Ethical approval 
 
Ethical approval from the local Research and Ethical Committee (REC) was confirmed to be 
in place prior to the commencement of the study. This was to cover the non-invasive and 
invasive elements of the work. Based on this, between May 2013 and June 2013, three 
patients undergoing TEVAR for symptomatic or rapidly enlarging chronic TBAD had invasive 
pressure recordings taken at the time of their procedure.  




Subsequent review of the ethics, post data collection indicated that the ethics approval in 
place was insufficient for the nature of the invasive investigation. Despite detailed clinical 
consent as well as that specifically for invasive pressure readings being sought from the 
patients, based on College recommendations this data was not given permission for use in 
this research study.  
Following on from this, a new application was made to the local REC and full ethical approval 
was granted in February 2014, for both prospective and retrospective data collection, for the 
invasive and non-invasive elements of the study. (REC reference: 14/LO/0286, London 
Bromley). However, based on the College’s review, the previously acquired invasive data 
was not permitted to be included.  
Additionally, subsequent changes in local surgical practice also meant that no TEVARs were 
undertaken for chronic TBAD between January 2014 and January 2015 (unless in a clinically 
urgent scenario, whereby recruitment was not deemed suitable as MRI scans of these 
patients could not be acquired safely). This meant that no further recruitment to the invasive 
study was possible. Ethical approval for the volunteer studies as well as for the subsequent 















7.1 General Computational Fluid Dynamics 
Methods 
 
7 . 1 . 1  C R I M S O N  
 
Creation of patient specific models using patient imaging data was performed using the in 
house CRIMSON software. CRIMSON (Cardiovascular Integrated Modelling and Simulation) 
is powerful, all-encompassing image-based blood flow simulation software capable of rapid 
and accurate segmentation of complex geometries, allowing generation of parametric 
models, surface and volume meshes, and specification of boundary conditions and output of 
files necessary for fluid flow simulation using the CRIMSON flow solver.  
The flow solver uses Windkessel outflow conditions coupled to each of the outlet faces of the 
aortic model. These Windkessel models require the specification of proximal and distal 
vascular resistance parameters (Rp and Rd, respectively) as well as a vascular compliance 
parameter (C) that represents the characteristics of the distal arterial bed not physically 
included in the 3D aortic model. These parameters are tuned to match patient pressure and 
flow data. 
CRIMSON was developed in the Figueroa Lab (Biomedical Engineering, at King’s College 
London) and has its foundations in the highly versatile MITK platform (Medical Imaging 
Interaction Toolkit www.MITK.org). Many of the original features of MITK have been 
preserved whilst others have been adjusted to provide a user-friendly method for 2D and 3D 
vessel segmentation. 
To create a geometric computer aided design model (CAD), the 2D segmentation methods 
introduced by Wang et al was utilized. (83) Technical details follow. 
 




7.1.1.1 Path l ines 
 
In this multi-step method, paths are defined through an approximate centreline of the blood 
vessel of interest. Each branching vessel has its own path line, although at bifurcations, one 
of the smaller vessels (e.g. external iliac) has a path extending from the parent (aorta) vessel 
(Figure 21). To develop a path line the selected image and vessel of interest are highlighted. 
Next path points are plotted in a 3D window, using the sagittal, coronal and axial image 
slices.  

















7.1.1.2 Contouring  
 
By creating a vessel path, “reslicing” of the image data is possible. The reslice plane displays 
the image data on the plane perpendicular to each point of the vessel path.  As the vessel 
path roughly approximates the vessel centreline, the reslice plane provides a reasonable 
cross-section of the vessel wall. Contours describing the boundary of the vessel wall and are 
created on the reslice plane at a number of locations along the vessel path (Figure 22). 
Fewer contours result in a smoother appearance of the resulting model. Care has to be taken 
at furcating points of vessels and in the case of dissection, the true and false lumens to 
ensure that contours do not intersect. This leads to ‘bleeding in’ of vessels and a model that 
cannot be used.  
 


















7.1.1.3 Lofting and Blending 
 
CRIMSON uses the (2D) contours to generate an analytical surface representation of the 
vessels by creating lofted B-spline surfaces between contours. Blending and union (lofting) 
operations are the final step to the creation of a 3D CAD representation of the patient’s aorta 
and main branches. Here a Boolean union operation is performed, merging the B-spline 
representations of the different branches into a single 3D CAD model. Sharp edges between 
any intersecting branches can be removed via a blending operation whereby a fillet of a 
given radius is introduced at each intersection (Figure 23). 


















7.1.1.4 Meshing operation 
 
Once a finite element mesh (e.g., discretisation of the geometry of the aorta in small pieces 
suitable for computational analysis) is generated, CRIMSON uses the MeshSim libraries 
(http://www.simmetrix.com/products/meshsim/MeshSim.html) to mesh the model with linear 
tetrahedral elements. Due to the no-slip condition (i.e. relative zero velocity between a 
viscous fluid, in this case blood, and the solid it interacts with, in this case the vessel wall at 
the fluid-solid interface) the region close to the vessel wall is typically the region with the 
highest velocity gradients in the domain. Therefore, it is desirable to refine the mesh close to 
the vessel walls. This may be done with the use of boundary layers.  
Another useful tool in the meshing operation is curvature refinement, which increases the 
surface mesh in regions of high curvature such as small vessels or branching points. Here 
complex flow profiles may be better captured.  For the purposes of this work a mesh size of 
1.0mm was used, with curvature refinement, giving an approximate mesh made of 1.4 million 
elements. Figure 24 shows the meshed model.  
 


















7 . 1 . 2  S i m u l a t i o n  
  
Computational fluid dynamics (CFD) analyses are performed on a 640-core SGI UV 1000 
super-computer with 4TB of RAM. Both meshing and CFD analysis tasks are carried out 
using the Crimson flowsolver code. The high-performance computer system is located at 
Guy’s campus, King’s College London. CFD results provide detailed information on spatial 
and temporal haemodynamic quantities such as blood velocity, blood pressure, and wall 


























8.1 Validation study Methods 
 
8 . 1 . 1  E q u i p m e n t  d e t a i l s  
 
Investigation of invasive intra-aortic (true and false lumen) haemodynamics was performed 
using a Certus PressureWire (St. Jude, MN, USA) (Figure 25). This is a strengthened 0.014” 
wire with high-fidelity sensor technology which allows for simultaneous measurement of 
intravascular pressure, temperature and thermodilution (84). A hydrophilic coating enhances 
manoeuvrability and device compatibility.  
The sensor element of the wire is located 3 cm proximal to the tip and three electrical cables 
run from the sensor to the proximal end of the wire.  
In conjunction with the RadiAnalyzer monitor (St. Jude, MN, USA) Figure 26, accurate (+/-1 
mmHg plus +/-1% of a reading) reading of intravascular pressure can be made and 
recordings taken for further analysis using the RadiView software (St. Jude, MN, USA). 
 
FIGURE 25 A CLOSE-UP VIEW OF CERTUS PRESSUREWIRE (84) 





8 . 1 . 2  S e t  u p  f o r  p r e s s u r e  w i r e  r e c o r d i n g  s t u d y  
 
All TEVAR procedures were performed under general anaesthesia with endotracheal 
intubation and ventilation, in the hybrid-operating suite at St. Thomas’s Hospital. This suite is 
equipped with state of the art interventional and open surgical facilities (Figure 27). Access to 
the femoral arteries was agreed upon preoperatively by the surgeons and interventional 
radiologists, as dictated by the anatomy and extent of the dissection. Prior to percutaneous 
vascular access, the pressure wire recording system and additional adjuncts were set-up. 
This setup enables simultaneous recording of aortic pressure and true or false lumen 
pressure once calibration has been performed (aortic pressure is monitored by a pig-tail 
catheter). An 8Fr sheath was usually used to access the chosen femoral artery and a pig-tail 
catheter passed up into the true lumen under fluoroscopy. Measurements of the non-
diseased (ascending) aortic pressure were recorded by the pigtail and used as reference for 
calibration of the pressure wire.  
Using a Y-connector, (SuperKetch, Minavasys, France) the pressure wire was inserted into 
the femoral artery and into the true or false lumen, under fluoroscopy. Pressure wire 
 
 
FIGURE 26 A SNAPSHOT OF THE RADIANALYZER MONITOR (A) AND SCREEN RECORDINGS 
DURING A TEVAR CASE (B) ARE SHOWN. RED TRACE = AORTIC PRESSURE, GREEN TRACE = 
FALSE LUMEN PRESSURE (84) 
 
 




recordings in each lumen were then taken for 10 seconds at each location, at 3-5 centimetre 
intervals. In all, the additional pressure measurements add a maximum of 5 minutes to the 
operative procedure. Details of each TEVAR procedure, including patient details and 




FIGURE 27 SET UP IN THE HYBRID THEATRE. WITH THE C-ARM IN POSITION, THE 
RADIANALYZER IS ATTACHED TO THE OPERATING TABLE. BOTH THE PRESSUREWIRE (PW, 
GREEN) AND THE PIGTAIL (AO, RED) ARE CONNECTED TO THE TRANSDUCER AT THE HEIGHT 
OF THE PATIENT’S RIGHT ATRIUM. 
 






























8 . 1 . 3  S u b j e c t s  
 
Three patients with chronic TBAD underwent TEVAR due to ongoing aortic expansion 
between May 2013 and July 2013.  Pressure wire measurements were recorded as detailed 
above, from both the true and false lumen at 5 cm intervals. Data was recorded in the 
RadiAnalyzer as well as handwritten in the proforma ( ). A further patient with acute TBAD 
was recruited and scanned during the acute presentation. Though this patient did not 
undergo TEVAR, the image data was used to create CAD models. 




Chapter 9  
 
9.1 Follow up study: Imaging methods  
 
Two patients who had undergone TAAD repair were invited for follow up scanning at a one-
year interval.  Patients were scanned in the Achieva 3T scanner (Philips Healthcare, Best, 
The Netherlands) with a 32-element coil at the Rayne Institute, King’s College London at St. 
Thomas’ Hospital. All images were reconstructed on the Philips scanner console using 
standard commercially available software. Details of image sequences have previously been 
described. (45) 
Sequences used to generate images included: 
a. Anatomy images: Isotropic 3D images of the aorta were acquired at least 10 minutes 
after the administration of contrast, (Multi-hance, Bracco spa, Milan, Italy) given at a 
dose of 0.2ml/kg, undiluted, to allow time for the contrast agent to fill the false lumen. 
Data were acquired with a respiratory navigator and ECG triggering to reduce 
respiratory and cardiac motion artefacts, respectively. All data were acquired in a 
single respiratory phase (5-mm gating window at end-expiration) and a single 
cardiac phase (mid-diastole, acquisition time 94ms). A k-space segmented inversion 
recovery prepared steady-state free precession sequence was used (field of view 
[FOV], 400 253 156mm3; acquired voxel size, 1.5mm3; flip angle, 20°; inversion time, 
350ms; repetition time [TR]/echo time [TE], 4.0/1.3ms; 22 k-space lines per cardiac 
cycle). Timing of the data acquisition from the R-peak (trigger delay) was determined 
from a 2-chamber view. The anatomy images were used to position 2D PC-MRI 
slices perpendicular to the aorta. 
 




b. 2D PC-MRI: Through-plane flow encoded images were acquired perpendicular to the 
aorta at three positions: the ascending aorta 15mm above the sinotubular junction, 
the arch of the aorta to capture the origin of the head and neck vessels and the 
descending thoracic aortic at the level of the diaphragm (including the true and false 
lumen). Data were acquired in free-breathing with ECG-gating, and data were 
retrospectively assigned to 25 cardiac phases (FOV, 300 300 mm2, slice thickness, 
10 mm; acquired voxel size, 1.9 mm2 ; flip angle, 10°; velocity encoding, 150-200 
cm/s; TR/TE, 5.2/2.9ms; temporal resolution, 34ms; number of signal averages, 2. 
The velocity encoding was set at 150 cm/s, and after the 2D PC-MRI acquisition was 
complete, the reconstructed images were checked immediately for aliasing. The 
velocity encoding was increased to 200cm/s or above if these were present, with 
data acquired again until a velocity encoding that correctly encoded for the peak 
velocity was achieved. These data were used to set up boundary conditions for the 
computational simulations and to verify the CFD solution. 
 
All MRI data was post processed using GTFlow Cardiovascular MRI Image analysis software 
(GTFlow 1.5.10, Gyrotools, Switzerland for flow analyses and Centricity PACS, GE-















Chapter 10  
 
10.1 Black blood study of aort ic wall  morphology 
 
T2 prepared inversion recovery and T2 prepared phase-sensitive inversion sequences allow 
the aortic lumen to appear dark and the aortic wall bright. This provides detailed vessel wall 
anatomy, which may help characterize the shape of the flap and potentially identify 
connecting tears between true and false lumen. This study focussed on investigating the 
utility of these two sequences, in particular the quality of images acquired and their potential 
use in dissection patients.  
 
1 0 . 1 . 1  I n - v i v o  e x p e r i m e n t s  
 
Eleven healthy volunteers and two patients with known chronic TBAD following repair of the 
Type A component underwent a three-dimensional anatomy scan. Two patients were part of 
a surveillance programme with CT scans at yearly intervals to detect changes in the 
morphology of the aorta. The study was approved by the local ethics committee and all 
participants provided written consent.  
All images were acquired on an Achieva 3T scanner (Philips Healthcare, Best, The 
Netherlands) at the Rayne Institute, King’s College London at St Thomas’ Hospital. with a 
thirty two-element cardiac coil and reconstructed on the scanner console using commercially 
available software. A T2 prepared Look-Locker scan was acquired in a sagittal orientation 
through the aorta with inversion pulses and imaging in every cardiac cycle to determine the 
optimal inversion time to null signal from blood for the T2IR scan (85). As T2PSIR is 
insensitive to deviations from the optimal inversion time for blood signal nulling the same 
inversion time for this scan. T2IR and T2PSIR sequences were acquired in all healthy 
volunteers in a randomized order. Two patients with aortic dissection were scanned with the 
T2PSIR sequence only.  




The T2prep module used an echo time of 40ms with two B1-insensitive adiabatic refocusing 
pulses for both T2IR and T2PSIR as shown in Figure 29a. (65,86) The T2IR and T2PSIR pre-
pulses were combined with a spoiled gradient echo sequence, acquired in a sagittal 
orientation using ECG-triggering and with the following imaging parameters: field-of-view = 
380 (foot-head) × 260 (anterior-posterior) × 50 (left-right) mm, spatial resolution = 1.3 mm3 
isotropic, SENSE = 2 (anterior-posterior). The acquisition window was set to 170ms to 
minimize cardiac motion artefacts. A pencil beam navigator positioned on the right hemi-
diaphragm was used to suppress respiratory motion artefacts with a gating window of 5 mm. 
For the T2PSIR approach, the gating was based on the navigator information of the first 














FIGURE 29 T2PSIR AND T2IR SEQUENCES. T2PSIR AND T2IR SEQUENCES (B). IN BOTH 
SEQUENCES AN INVERSION PULSE IS PERFORMED TO NULL THE SIGNAL FROM BLOOD AND A 
T2PREP, USING 2 ADIABATIC REFOCUSSING PULSES (A), IS PERFORMED TO IMPROVE THE 
CONTRAST BETWEEN BLOOD AND VESSEL WALL. IN THE T2PSIR SEQUENCE AN ADDITIONAL 
IMAGE ACQUISITION IS PERFORMED IN THE SUBSEQUENT CARDIAC CYCLE TO CALCULATE 
THE POLARITY OF THE SIGNAL (C). TO MINIMIZE FLOW ARTEFACTS ORIGINATING FLOWING 
BLOOD DURING THE PERFORMANCE OF THE T2PREP THIS PRE-PULSE IS PERFORMED IN 
EARLY SYSTOLE IMMEDIATELY AFTER R-WAVE DETECTION. THE INVERSION TIME IS 
DETERMINED SUCH THAT BLOOD SIGNAL IS NULLED FOR T2IR WHILE FOR T2PSIR BLOOD 











1 0 . 1 . 2  P i l o t  s t u d y :  o p t i m i z i n g  p a r a m e t e r s  t o  e n s u r e  
f l o w - i n d e p e n d e n c e  
 
Although the inversion pulse is flow-independent, a previous study has demonstrated that the 
T2 prepared pulses are to some extent flow-dependent (87). This flow dependency is 
exacerbated at high fields such as 3T due to increased B1 and B0 inhomogeneities (87). B0 
inhomogeneities can be also interpreted as an additional time independent and constant 
background gradient field, Gbg.  
In practice, this means that during the application of the T2 prepared prepulse in the 
presence of this background gradient field, the transverse magnetization of flowing blood 
experiences some de-phasing proportional to the flow velocity. This may result in only 
partially suppressed blood signal in the T2IR and T2PSIR images and areas of bright-blood 
signal (or flow artefacts) in regions with high velocity blood flow.  
The flow-dependency of the T2 prepared pulses may be particularly noticeable if they are 
performed in a cardiac phase with high velocity flow, such as during peak systole. To 
investigate the flow-dependence of the T2 prepared pulses and the subsequent effect on the 
proposed black-blood scans we performed a pilot study in two healthy subjects (volunteers 
10 and 11) where we modified the temporal position of the T2 preparation (and subsequent 
inversion pulse) in the cardiac cycle. In this study, a phase-contrast image was first acquired 
orthogonal to the ascending and descending aorta to measure flow.  
From this image we identified a cardiac phase with low flow, in early-systole (0-50 ms after 
the R-wave) and one with high flow in mid-systole (200-250 ms after the R-wave). We then 
acquired one scan with the preparation pulses (T2 preparation and inversion) performed in 
mid-systole (high flow) and another scan with the preparation pulses performed immediately 
following the R-wave in early systole (low flow). However, by adjusting the temporal position 
of the T2 prepared pulses to early systole, which has less flow, the flow artefacts can be 
avoided. For the remaining healthy volunteer and patient scans the T2 prepared and 




inversion pulse were performed in early systole immediately following the R-wave with image 
acquisition in mid-diastole (Figure 30). 
 
 
FIGURE 30 IMAGES OBTAINED FROM ONE OF THE TWO PILOT STUDY SUBJECTS 
DEMONSTRATING FLOW DEPENDENCE OF T2PSIR. THE CHART ON THE RIGHT DEMONSTRATES 
FLOW IN THE ASCENDING (RED, AA) AND DESCENDING AORTA (BLUE, DA), OVER TIME AND THE 
TIME-POINTS IN THE CARDIAC CYCLE WHEN THE T2PREP WERE PERFORMED FOR THE LOW AND 





1 0 . 1 . 3  D a t a  a n a l y s i s  a n d  s t a t i s t i c s  
 
Comparison between the T2IR and T2PSIR sequences was based on image quality scores, 
which included a visual scoring system, apparent contrast-to-noise ratio (aCNR) as well as 
the sharpness of the images as calculated using dedicated software.(88) The sharpness 
measurements were performed on a 4-centimetre segment on the vessel wall–lumen 
interface of the descending aorta. The aCNR was calculated between the aortic vessel wall 
and aortic luminal blood, with signal noise obtained from a region of air in the lung (avoiding 
any vasculature). The visual scoring system used ranged from 1-4 where 1 signified poor 
image quality and 4, excellent image quality (89). Two blinded experts were asked to 




compare the two sequences and score them in each volunteer. The scan time for each 
sequence per patient was also recorded. Statistical analysis was carried out using the 
Wilcoxon signed-rank test, at p<0.05 and a kappa statistic to compare subjective agreement 
between the two raters. For the Wilcoxon test, a W value was calculated, which, if less than 





























11.1 Dual phase study for aort ic motion and 
strain: imaging methods 
 
 
1 1 . 1 . 1  S t u d y  p o p u l a t i o n  
 
Five healthy volunteers and two patients with a TAAD repair and a residual Type B 
component were included in this study. All subjects provided written consent. 
 
1 1 . 1 . 2  I m a g e  a c q u i s i t i o n  
 
Image acquisition in MRI scanning generally occurs in diastole where there is less cardiac 
and blood motion and therefore fewer artefacts.  For the purpose of this study, to evaluate 
aortic motion and changes during the cardiac cycle, images were obtained in systole and 
diastole.  
All images were acquired on an Achieva 3T scanner (Philips Healthcare, Best, The 
Netherlands) at the Rayne Institute, King’s College London at St. Thomas’ Hospital, with a 
thirty two-element cardiac coil and reconstructed on the scanner console using commercially 
available software. 3D coronal images were acquired in all subjects.  
Imaging parameters at 3T for both sequences include: TR/TE = 5.0/2.3 ms, acquisition 
duration = 100ms, T2prep echo time = 70ms, FOV = 264×380×46 mm
3, 
Δx = 1.6×1.6×1.6 mm3, α = 20  for the first acquisition and 5  for the PSIR reference 
acquisition, SENSE factor = 2 (anterior-posterior). A pencil beam navigator was used for 
respiratory gating, with a 5 mm gating window. A cine phase contrast scan was performed in 
order to determine the blood flow in the ascending aorta just distal to the aortic valve and to 
determine the cardiac phase. Data acquisition was performed in systole and diastole in all 
subjects (n=7). 




1 1 . 1 . 3  I m a g e  s e g m e n t a t i o n   
 
CRIMSON was used as described before to segment the aorta and identify the points of 
interest this time using MRI derived images. Pathlines were created from which contours 
were mapped and a solid volume CAD model was interpolated. The image data and resulting 
3D model were compared to resolve any inaccuracies. Initially, diastolic and systolic models 
for each patient were created and superimposed to show a visual depiction of motion from 
diastole to systole (Figure 31). 
To allow for comparable analysis, dimensions of each contour at each of the desired 
locations were calculated in CRIMSON for each subject, in diastole and in systole. This 
provided information circumferential change. Additional methods of comparison included 
strain calculations. 
To determine a longitudinal strain, a centreline was developed in the aorta, without any 
branching vessels attached. A mesh was created for the aorta and was repeated for each 
isolated segment of the aorta. CRIMSON was used to calculate the volume for each isolated 
mesh for each isolated segment of the aorta. The centreline for each segment was calculated 
by importing the meshed segments into VMTK (vascular modelling tool kit). (90)  
The true and false lumen were segmented as ‘separate vessels’ in the case of aortic 
dissection.





FIGURE 31 IMAGE SEGMENTATION FOR THE DUAL PHASE STUDY.  
 
1 1 . 1 . 4  I m a g e  a n a l y s i s  
 
Initial work on this study lead to the development of segmented models of all subjects in 
systole and in diastole. It was apparent however, that there were two problems. The first 
issue related to the use of flow to determine the phase of the cardiac cycle. Initial scans for 
systole were triggered at a time of maximal flow which corresponded to early systole. Here 
however, on image analysis there was not much difference in cardiac motion (Figure 32, 
Figure 33). Image analysis showed a very similar state of the heart and the aorta when 
imaged in systole or in diastole. This was very early in systole when the motion of the heart 
resembled very late diastole. All subsequent imaging was done using cine imaging whereby 
flows across the aortic valve were determined.  A flow curve was generated to determine 








FIGURE 32 SYSTOLIC AND DIASTOLIC IMAGES FROM THE SAME SUBJECT. NOT MUCH 




FIGURE 33 CINE TRIGGERED SCANS SHOW A DIFFERENCE IN SYSTOLIC AND DIASTOLIC STATES 
OF THE HEART.  





FIGURE 34 AN ALTERNATE STRATEGY OF INCLUDING A CINE IMAGE WITH DYNAMIC CARDIAC 
IMAGING TO DETERMINE SYSTOLE AND DIASTOLE WAS INCLUDED IN ADDITION TO CALCULATING 
FLOW IN THE ASCENDING AORTA ABOVE THE LEVEL OF THE AORTIC VALVE WITH PC-MRI.  
SYSTOLIC IMAGING WAS THEN TRIGGERED AS SHOWN BY THE RED ARROW AND DIASTOLIC BY 
THE BLUE ARROW. 
 
The second issue with dual phase imaging related to the discrepancy between image 
datasets, which meant that not all subjects had full image data sets extending into the 




abdominal aorta. This meant that for accurate comparison, fixed points that were visible in all 
subjects were essential rather than arbitrary aortic lengths Following on from this, four 
discrete points from the aorta were identified for all subjects in both the systolic and diastolic 
datasets. These were: 
1. distal to the left coronary artery (LCOA), 
2. proximal to the innominate artery (P.InoA), 
3. distal to the left  subclavian artery (LSCA)  
4. the 1st intercostal artery and  
5. the 5th intercostal artery (5th IcoA).  
These were chosen for two reasons. Firstly as these points were easily identifiable on the 
image data in all subjects and secondly because they allowed the aorta to be divided into 
specific portions, namely the; 
1.  ascending aorta (AAo, distal to the left coronary artery and proximal to the P.InoA) 
2. The arch (AA, from the P.InoA to distal to the LSCA) 
3. The descending aorta (DA distal to the LSCA and to the 5th IcoA) 
therefore allowing for comparable analysis. (Figure 35) 
 





FIGURE 35 REPRESENTATION OF THE AORTA IN THE DUAL PHASE STUDY. THE AORTA WAS 
DIVIDED INTO SEGMENTS TO ALLOW FOR COMPARATIVE ANALYSIS. THE POINTS 1-4 SERVE 
TO DISTINGUISH BETWEEN THE ASCENDING AORTA (1-2), ARCH (2-3) AND DESCENDING 
AORTA (3-4).  
 




1 1 . 1 . 5  A n a l y s i s  o f  a o r t i c  m o t i o n  a n d  s t r a i n  
 
Initial analysis was focused at studying the change in the positon of a chosen coronary artery 
in each subject between systole and diastole. Further analysis investigating longitudinal, 
circumferential and volumetric changes in the aorta were later included  
Strain is defined as the deformation of a material from reference morphology to a new 
morphology, when experiencing an external force. The Green-Lagrange tensor was used to 
calculate circumferential (EC) and longitudinal (EL) deformations in length (l) and this is 
independent and suitable for large strains 
 
𝐸 =   𝑙!! − 𝑙!!2𝑙!!  
For volumetric strain (EV), the following equation was used,  
 
𝐸! =   Δ𝑉𝑉!  
where Δ𝑉= VS-VD  and VS represents the volumetric strain in systole and VD the volumetric 















12.1 TEVAR Study Results 
 
Three patients underwent TEVAR for on-going dilatation of the thoracic aorta following on 
from their acute TBAD event. A fourth patient presented with an acute TBAD, in November 
2014, and was originally planned to undergo TEVAR. Close monitoring and blood pressure 
management of this patient led to change in the decision to a conservative strategy.   
However, in anticipation of the original plan of TEVAR, the patient was recruited and 
underwent MRI scanning, and CT image data was acquired to develop a CAD model. Table 
2 shows the demographics of the recruited patients. Figure 36 is a CT image library of the 4 
TEVAR patients.  
 
TABLE 2 DEMOGRAPHICS OF THE TEVAR POPULATION PATIENTS 
Pt Id Age 
(y) 
Sex Date Type of dissection Reason for TEVAR 
1 60 M April 2013 Acute TBAD Acute chest and abdominal pain 
2 59 M May 2013 Acute TBAD Symptomatic and size >5.5cm 
3 47 F Oct 2002 Chronic TBAD Rapidly increasing size 
4 30 M Aug 2014 Acute TBAD TEVAR not performed 






FIGURE 36 CT LIBRARY OF IMAGES FOR ALL TEVAR PATIENTS 1-4, 








A 60-year-old gentleman was referred from Exeter University Hospital with a 2-day history of 
acute dyspnoea and central chest pain. He had a history of hypertension and had undergone 
a laparotomy for a bleeding gastric ulcer 19 years ago. A CT scan performed at the referring 
hospital demonstrated a TBAD originating in the descending aorta at the level of the 
diaphragm. The right renal artery was fed by the false lumen whereas the rest of the visceral 
vessels originated from the true lumen. In view of on-going abdominal pain and concerns 
regarding gut malperfusion, the patient was referred to St. Thomas’ Hospital. On arrival, 
intravenous beta-blockade was commenced but despite adequate hypertensive control, the 
persistence of abdominal symptoms prompted the decision for surgical intervention.  
 
12.1.1.2 Preoperative Imaging 
 
CT imaging was performed as per clinical routine protocol (Figure 37). MRI using the 
previously mentioned sequences was performed.  
 
12.1.1.3 Procedure: TEVAR for symptomatic TBAD 
 
Arterial access was achieved via the right femoral artery, using an 8Fr sheath. A pigtail 
catheter was inserted into the aorta and calibration with the RadiAnalyzer system was 
performed. Next, the PressureWire Certus (PW) was calibrated before insertion, as per 
manufacturer’s instructions and inserted within the SuperKetch Y-connector. True lumen and 
corresponding aortic measurements were taken followed by false lumen and aortic 
measurements.  
 




12.1.1.4 Non-invasive haemodynamic study- workflow process 
leading to simulation 
 
Using CRIMSON software a CAD model was developed for Patient 1, using anatomic data 
from a preoperative clinical CT scan (2D PC-MRI data was post processed in GTFlow 
(Switzerland) to determine a velocity and flow profile for specific regions of the aorta 
(ascending, arch and descending aorta) using contours to define the vessels of interest The 
resulting data was input into a spreadsheet to determine a velocity and flow profile for the 
chosen vessel.  (Figure 38) 
 
 
FIGURE 37 PATIENT 1. ACUTE TBAD IMAGES FROM CT SCANS AT PRESENTATION. BLUE 
ARROW INDICATES THROMBUS FORMATION. RED ARROW INDICATES THE POSITION OF 
THE TRUE LUMEN. GREEN ARROW INDICATES LOCATION OF INTIMAL TEAR.  
 





FIGURE 38 WORKFLOW FOR CREATING A 3D CAD MODEL FOR SIMULATION. A. IMAGE DATA IS 
USED TO CREATE GEOMETRY IN CRIMSON. B A 3D CAD MODEL IS DEVELOPED. C. FLOW DATA IS 
ACQUIRED FROM PC-MRI USING GT-FLOW. D. FLOW DATA IS CONVERTED INTO GRAPHICAL 
FORMAT. 








A 59-year-old gentleman was admitted to Woolwich Hospital with a 6-month history of 
dyspnoea, anorexia and weight loss. There was no history of acute chest or back pain and 
although he had been diagnosed with hypertension a year previously, he had not received 
treatment for this. His baseline blood pressure on admission was 180/70mmHg. In view of 
his symptoms of dyspnoea, he underwent CT scanning which demonstrated a TBAD, 
immediately distal to the left subclavian artery. The presence of a large descending aortic 
component prompted transfer to St. Thomas’ Hospital for intervention. Preoperative 
management at St. Thomas’ included continuous veno-venous filtration in view of his renal 
impairment and intravenous beta-blockade combined with GTN to control hypertension. 
 
12.1.2.2 Preoperative imaging 
 
Preoperative CT scan demonstrated a dissection in the descending aorta distal to the left 
subclavian artery (Figure 39). 
 
12.1.2.3 Procedure: TEVAR for symptomatic TBAD 
 
Access was achieved via the right femoral artery, using an 8Fr sheath. A pigtail catheter was 
inserted into the aorta and calibration with the RadiAnalyzer system was performed. Next, 
the PW was calibrated before insertion, as per manufacturer’s instructions and inserted 
within the SuperKetch Y-connector. True lumen and corresponding aortic measurements 
were taken followed by false lumen and aortic measurements.  
 




12.1.2.4 Non-invasive haemodynamic assessment  
 
To obtain non-invasive haemodynamics, 2D PC-MRI data was post processed in GT Flow, to 
obtain velocity profiles at 3 different levels in the aorta, namely the ascending aorta (Ao1), 
the arch vessels (Ao2) and the descending aorta at the level of the diaphragm (Ao3). These 
velocity profiles were used to develop the simulation process. Figure 40 shows the workflow 
process of developing the CAD model in CRIMSON and the use of GTFlow to post-process 
MRI data to obtain velocity profiles in this instance at the arch outflow level. 
 
 
FIGURE 39 CT IMAGES OF PATIENT 2. THE RED ARROW SHOWS THE TRUE LUMEN, THE YELLOW 
ARROW INDICATES THE FALSE LUMEN.  
 





FIGURE 40 WORKFLOW FOR PREPARING A MODEL FOR SIMULATION. A. 3D GEOMETRY FROM 
IMAGE DATA RESULTS IN B. AN ANATOMICALLY ACCURATE MODEL. C AND D. GT FLOW IS USED 
TO EXTRACT RELEVANT FLOW DATA AT VARIOUS POINTS IN THE AORTA. E. THE FLOW DATA IS 
CONVERTED INTO EXCEL READY FOR USE IN SIMULATION.  








In December 2002, A 57 year old female presented with acute chest and back pain and an 
ischaemic right leg. Subsequent investigations demonstrated a TBAD with compromise of 
the right external iliac artery. In addition, an anatomical anomaly of an aberrant right 
subclavian artery was detected. A Zilver stent was inserted to allow revascularisation of the 
right leg, with effective results. In view of the otherwise stable nature of the dissection, the 
patient was entered into a close monitoring programme with 6 monthly CT evaluation.  
In January 2013, however, a rapid increase in the false lumen size was detected compared 
to previous scans and a decision was made to perform TEVAR preceded by arch 
debranching to allow for a comfortable proximal landing zone and re-routing of the aberrant 
right subclavian artery.  
 
12.1.3.2 Procedure: TEVAR for enlarging aortic diameter 
 
Arterial access was achieved via the right femoral artery, using an 8Fr sheath. A pigtail 
catheter was inserted into the aorta and calibration with the RadiAnalyzer system was 
performed. Next, the PW was calibrated before insertion, as per manufacturer’s instructions 
and inserted within the SuperKetch Y-connector. True lumen and corresponding Figure 41 
shows the preoperative CT. 
 





FIGURE 41 PATIENT 3. A: PRE-OPERATIVE CT SCAN WITH RED ARROW HIGHLIGHTING THE 






















A 30 year old gentleman with a history of severe, uncontrollable hypertension presented with 
acute chest and back pain in September 2014.  He was diagnosed with a TBAD on CT scan 
(Figure 42). His BP at the time of MRI was 208/147mmHg. Anti-impulse therapy was 
commenced and the symptoms subsided. In view of this he was monitored closely and 
eventually the decision to manage conservatively with a repeat CT scan in 4 months’ time 
was made. Figure 43 shows the CAD models developed for Patient 4 using CRIMSON. 




FIGURE 42 CT SCAN IMAGES FROM A 30-YEAR OLD MALE WITH AN ACUTE TBAD. THE 
GREEN ARROW INDICATES THE POSITION OF THE INTIMAL FLAP. THE YELLOW ARROW 
INDICATES THE FALSE LUMEN AND THE RED ARROW THE TRUE LUMEN.  




                      
                               
FIGURE 43 A 3D MODEL OF PATIENT 4 SHOWING THE TRUE (BLUE) AND FALSE LUMEN (PINK). 
NO THROMBUS WAS PRESENT DUE TO THE ACUTE NATURE OF THE DISSECTION. 











FIGURE 44 PATIENT 4. 3D MODEL WITH AREA OF TEAR (GREEN ARROW) HIGHLIGHTED AND 
CORRESPONDING CT IMAGE SHOWING THE SAME.  
 
    




12.2 Recording of pressure wire results 
 
Figure 45 shows an example of results obtained from a pressure wire study during TEVAR 
for a patient with TBAD. In patients with an acute pathology the false lumen pressure was 
seen to be larger than in those with a more chronic pathology.  
 
 





FIGURE 45 PROFORMA FROM AN EXAMPLE OF A HYPOTHETICAL TEVAR CASE SHOWING 
RECORDING OF INTRA-AORTIC HAEMODYNAMICS. PRESSURE WIRE RESULTS WERE PLOTTED 













13.1 Follow up study results 
 
Three patients were recruited into the follow up study arm. All had undergone acute repair for 
TAAD and had a residual Type B component that was being monitored with serial CT scans 
on an annual basis. Two patients had two scans performed each, one year apart. The final 
patient was recruited late and therefore had only one scan performed.  






















Sex Dissection  Post-operative 
result 
CT images MRI scans 




   Sept 2013 
   May 2014 




  Aug 2013 
  Mar 2014 




Aug  2013 
July 2014 


















1 3 . 1 . 1  F o l l o w  u p  p a t i e n t  1  
 
A 63 year old gentleman with a history of hypertension had an acute TAAD in 2011. He 
underwent emergency repair of the ascending aorta and made an excellent post-operative 
recovery. The residual TBAD was noted preoperatively on the CT scan and the patient was 
eventually discharged home with annual CT scan follow up.  
This patient attended for 2 MRI scans one year apart. The sequences performed as 
described in the general material and methods.  
2D PC-MRI data was acquired at each scan session and two CAD models demonstrating the 
aortic geometry one year apart were developed the CT image data within CRIMSON 
software.  Figure 46 shows the completed CAD model with and without the thrombus lofted in 
as well as the thrombus as a separate entity.  Figure 49 shows the same for the same patient 
one year later.  
In Figure 48 the method of determining thrombus presence is shown using CRIMSON.  
Table 4 shows the quantitative morphological changes over the one year period with respect 
to the volume of the true and false lumens and the thrombus. There has been a decrease in 
the false lumen volume and an increase in thrombus formation over the course of the year.  
Figure 49 and Figure 50 show the changes with respect to tear morphology. The main 
change was the healing of tear at location 4 in 2013. Finally, simulation was performed on 
these CAD models (without the thrombus lofted in). The results are shown in Figure 51, 
Figure 52 and Figure 53. Of note, the overall intra-aortic pressure was lower in 2014 than in 
2013. Additionally the area of tear 4 had a low velocity and pressure overall at baseline in 
2013 and it is not surprising that a year later this tear had healed. Finally, the proximal false 
lumen showed a high pressure at baseline and although this was lower the following year, it 
still represented a higher pressure area than the distal false lumen. This could mean that the 
proximal false lumen is pressurised blind sac. 




Finally Figure 54 shows the comparison of PC-MRI derived parameters and those from CFD. 




FIGURE 46 PATIENT 1 IN 2013. THE TRUE LUMEN IS SHOWN IN BLUE, FALSE IN PINK AND 
THROMBUS IN BROWN.  
 





FIGURE 47 PATIENT 1 IN 2014. THE TRUE LUMEN IS SHOWN IN BLUE, FALSE IN PINK AND 




FIGURE 48 PATIENT 1 THROMBUS VOLUME IS 2014 WITH CORRESPONDING CT IMAGE 










TABLE 4 MORPHOLOGICAL CHANGES OVER THE PERIOD OF ONE YEAR FOR PATIENT 1. THE 
FALSE LUMEN VOLUME HAS DECREASED AND THROMBUS VOLUME HAS INCREASED.  
Year TL (mls) FL (mls) Thrombus (mls) 
2013 256 50.08 55.2 





FIGURE 49 CAD MODELS FOR PATIENT 1 IN 2013. THE TEARS ARE MARKED IN YELLOW AND 
BLACK ARROWS.  






FIGURE 50 CAD MODELS FOR PATIENT 1 IN 2014. THESE MODELS SHOW THE CHANGE IN TEAR 















FIGURE 51 SIMULATION RESULTS FROM PATIENT 1. MEAN PRESSURE IS SHOWN ON THE LEFT 
AND MAXIMUM VELOCITY ON THE RIGHT.  TOP: 2013 RESULTS, BOTTOM: 2014 RESULTS.   OF 
IMMEDIATE NOTE IS THE OVERALL LOW MEAN PRESSURE THROUGHOUT THE AORTA AND IN 
PARTICULAR THE FALSE LUMEN DISTALLY WHEN COMPARED TO THE PREVIOUS YEAR. 
ADDITIONALLY A LOWER VELOCITY PROFILE IS EVIDENT IN THE AREA OF HEALED TEAR 4.  
 





FIGURE 52 SIMULATION RESULTS FOR 2013 LEFT: PRESSURE, CENTRE: VELOCITY AND RIGHT 
TEAR MORPHOLOGY. OF NOTE: AREA OF TEAR 1 HAS A HIGH PRESSURE BUT LOW VELOCITY 
POTENTIALLY REPRESENTING A PARTIAL THROMBOSIS OF THE PROXIMAL FALSE LUMEN. TEARS 


















FIGURE 53 SIMULATION RESULTS FOR 2014 LEFT: PRESSURE, CENTRE: VELOCITY AND RIGHT 
TEAR MORPHOLOGY. OF NOTE: THE OVERALL MEAN PRESSURE SEEMS TO BE LOWER IN 2014. 
IN PARTICULAR THIS IS TRUE FOR THE DISTAL FALSE LUMEN. TEARS 2,3 AND 5 STILL SHOW A 
TURBULENT FLOW PATTERN WHEREAS TEAR 4 HAS NOW HEALED FULLY AND IS NOT SEEN IN 















FIGURE 54 AGREEMENT BETWEEN PC-MRI AND CFD SIMULATION FLOW RESULTS FOR 
PATIENT 1. TOP: 2013 RESULTS. BOTTOM: 2014 RESULTS.  
 
1 3 . 1 . 2  F o l l o w  u p  p a t i e n t  2  
 
In 2008, A 30 year old pregnant female at 35 weeks gestation presented to the A&E 
department with acute chest pain. She was diagnosed with an acute TAAD by MRI scanning 
and underwent emergency C-section followed by repair of the ascending aorta. She made an 
excellent recovery and was discharged home within the week, with regular post-operative 
follow up arranged. Although she presented back to the A&E up to 4 times in the next year 
with acute chest pain, and underwent repeated CT scanning, no abnormality was found.   
This patient underwent two MRI scans one year apart and data from these along with her 
annual CT scans was used to develop CAD models. Simulation was not possible due to time 
and expense constraints.   shows the completed CAD models for patient 2 and Figure 56 
shows the identification of tears (yellow) and the true and false lumen geometry as seen in 
CRIMSON. The main point noted in these models was the lack of any thrombus despite the 
age of the dissection and the number of tears identified (9 tears).  
Table 5 shows the volume of true and false lumens and the combined tear volume in each of 
the models. The combined tear volume seems to have increased slightly and that of the true 
lumen decreased slightly. The false lumen volume has increased marginally. Figure 57 and 



















FIGURE 55 PATIENT 2. CAD MODELS OF AORTIC DISSECTION OVER THE PERIOD OF ONE YEAR. 
THE FALSE LUMEN IS WIDELY PATENT WITH NOT MUCH CHANGE IN SIZE OVER THE YEAR AND NO 






TABLE 5 VOLUME OF TRUE & FALSE LUMENS AND TEARS 
Year TL volume (mls) FL volume (mls) Combined tear 
volume (mls) 
2013 104 215 1.48 
2014 90 217 1.61 
   





FIGURE 56 PATIENT 2. CAD MODEL DEVELOPMENT IN CRIMSON. TRUE LUMEN IS SHOWN IN 
BLUE, FALSE IN PINK. TEARS ARE SHOWN IN YELLOW. 





FIGURE 57 TEAR MORPHOLOGY FOR PATIENT 2. NINE TEARS WERE FOUND AND NO THROMBUS 
HAD DEVELOPED SINCE THE ORIGINAL ACUTE DISSECTION 5 YEARS AGO. 







FIGURE 58 TEAR MORPHOLOGY FOR PATIENT 2. ALL 9 TEARS WERE FULLY PATENT ONE YEAR 











1 3 . 1 . 3  F o l l o w  u p  p a t i e n t  3  
 
The third patient was a 56 year old gentleman who presented with acute chest and back pain 
in 2012. Subsequent CT scanning revealed a complex acute TAAD extending into the head 
and neck vessels and down into the femorals. The patient underwent repair of the ascending 
aorta and was eventually discharged. He represented with transient ischaemic attacks but 
these subsided. Follow up imaging was performed on an annual basis. For this patient 2 
follow up MRI scans approximately a year apart and in close proximity to the clinically 
requested CT scans were performed. Although simulation data has not yet been completed, 
the preliminary flow analysis and CAD models were developed for the baseline scan (Figure 
59). This patient had an extremely complex dissection geometry making it difficult to develop 
accurate CAD models.  






FIGURE 59 BASELINE CAD MODEL FOR PATIENT 3 AND CORRESPONDING CT SCAN. THIS WAS 
A COMPLEX DISSECTION EXTENDING INTO THE ARCH AND THE SUPERIOR MESENTERIC ARTERY. 
















1 3 . 1 . 4  F o l l o w  u p  p a t i e n t  4  
 
In 2012, a 54 year old gentleman presented with acute chest pain and ECG findings 
consistent with a non-ST elevation MI. He underwent primary percutaneous intervention to 
the circumflex coronary artery. At this procedure an iatrogenic TAAD occurred. The patient 
therefore underwent emergency surgery to repair the ascending aorta.  
A CAD model was developed from the primary CT scan following on from the iatrogenic 
dissection and subsequent MRI scans performed in May and December of 2014. 
Unfortunately due to late recruitment as a result of patient unavailability no further CT scans 
were possible to acquire during the study period.  
Nonetheless, a CAD model was developed with the intention of processing for simulation. 
Figure 60 shows the CAD models without and with the thrombus lofted in Figure 61 shows 
the identification of tears using CRIMSON. The reslice plane is seen to be moving down the 


















FIGURE 60 PATIENT 4. CAD MODEL OF AORTIC DISSECTION. THE PICTURE ON THE TOP SHOWS 
THE THROMBUS LOFTED IN (BROWN) 





FIGURE 61 PATIENT 4. CAD MODELS SHOWING LOCATION OF TEARS (YELLOW). THERE WERE 
FOUR TEARS IN TOTAL. 
 
 








14.1 Black blood study results 
 
Three-dimensional T2IR and T2PSIR vessel wall images were successfully obtained in all 11 
volunteers and two patients. Demographics of the subjects are shown in Table 6. 
Representative images from three healthy volunteers, reformatted to visualize the ascending 
and descending aorta using the two sequences are shown in Figure 62. Visual scores by two 
independent raters are shown in Table 7.  
The W values calculated by the Wilcoxon signed rank test for comparison for aCNR, scan 
time and sharpness between the two sequences at p<0.05 were zero, which were deemed 
statistically significant.  
These results indicate that the T2PSIR sequence, although longer in duration (T2PSIR 703.7s 
± 210s vs. 443.2s ±251 s for T2IR, median 1.9 times longer), provided better quality, with 
improved objective and subjective image quality as ascertained by the sharpness and aCNR 
when compared to the T2IR sequence.  
The visual score results were cross tabulated and the calculated kappa statistic for inter-rater 
agreement for both sequences was high, indicating good agreement between the experts, for 
both sequences in all volunteers. Additionally it was seen that the T2PSIR sequence 
performed better on the visual score across all except two subjects where it scored the same 
as the T2IR sequence. Figure 63 shows the images acquired using the T2PSIR sequence in 
two patients with a chronic TBAD, who have previously had a TAAD repair. The intimal flap is 
clearly visualized in both patients. Corresponding CT images are shown for visual 
comparison. 
 













37 M - - - 
V2 38 M - - - 
V3 32 M - - - 
V4 28 M - - - 
V5 33 F -  - 
V6 34 M - - - 
V7 30 M -  - 
V8 32 M - - - 
V9 27 M - - - 
V10 25 F - - - 
V11 26 F - - - 
P1 57 M 27 months Hypertension Transient ischemic 
attack 











                            TABLE 7 VISUAL SCORE RESULTS FOR EACH OF THE SEQUENCES 
           Visual Score T2IR 
Rater 1 Rater 2 
VS                                 VS 
 
1 2 3 4 
1 6 2 0 0 
2 0 3 0 0 
3 0 0 0 0 
4 0 0 0 0 
         Visual Score T2PSIR 
Rater 1 Rater 2 
VS                                   VS 
 1 2 3 4 
1 1 0 0 0 
2 0 2 1 0 











FIGURE 62 REFORMATTED IMAGES FROM THREE HEALTHY VOLUNTEERS USING T2IR AND 
T2PSIR. A CLEARER IMAGE WITH BETTER VESSEL WALL VISUALIZATION IS OBTAINED WHEN 
USING THE T2PSIR SEQUENCE. 






FIGURE 63 SAGITTAL SECTION IMAGES SHOWING T2PSIR SEQUENCES PERFORMED IN TWO 
PATIENTS WITH CHRONIC TBAD. THE WHITE ARROWS SHOW THE POSITION OF THE INTIMAL 
FLAP, WHICH IS CLEARLY VISUALIZED. CROSS-SECTIONS OF EACH PATIENT’S A) CT SCAN AND 
B) MRI (T2PSIR) SEQUENCE ARE SHOWN BELOW THE SAGITTAL IMAGES. THE RED ARROWS 

















15.1 Dual Phase results 
 
Five healthy volunteers and two patients with repaired TAAD were recruited into the dual 
phase study. Demographics of the study subjects are shown in   Table 8.  
 
  TABLE 8 STUDY POPULATION DEMOGRAPHICS. V=VOLUNTEER, P=PATIENT 
Subject  Age (y) Sex Smoker History 
V1 32 F N - 
V2 30 M N - 
V3 29 M N - 
V4 24 M Y - 
V5 23 F Y - 
P1 50  Y TAAD with residual Type B component 
P2 42  Y TAAD with residual Type B component. 
Connective tissue disorder 
 
 
All subjects were successfully scanned in systole and in diastole and dual phase models 
were created in CRIMSON for each subject. Figure 64 shows the dual phase model for one 
healthy volunteer (V1). For all volunteers, the aorta root moved inferiorly during systole. The 
motion of the let coronary artery was mapped in each healthy volunteer by picking the first 
coordinate in the pathline for the left coronary artery in each of the models (Figure 65). The 
left coronary artery was chosen as it was visible in all scans between and across the 
volunteers. Table 9 shows these results. In this method, the average travel for the left 
coronary artery in systole was 6.5mm in the horizontal direction, 4.2mm in the inferior 




direction and 7.9mm in the z axis. The net motion therefore for the left coronary artery was 
11.7mm.   
The mean circumferential, longitudinal and volumetric strain for each volunteer was also 
calculated as described previously. Additionally the circumference for each chosen point was 
determined in CRIMSON. The change in circumference gave an indication of the change in 
size of the true and false lumen during the cardiac cycle.  
 
 
FIGURE 64 DUAL PHASE MODELS. BLUE DIASTOLE, RED, SYSTOLE. THE SUPERIMPOSED IMAGE 
ON THE FAR RIGHT SHOWS THE CHANGES IN AORTIC MOTION WITH THE CARDIAC CYCLE. THE 
AORTIC ROOT IS SEEN TO BE TRAVELLING IN THE INFERIOR-LATERAL DIRECTION DURING 











FIGURE 65 ENLARGED VERSION OF THE AORTIC ROOT OF A VOLUNTEER. HERE THE MOTION OF 
THE LEFT CORONARY ARTERY IS VISUALIZED AND HIGHLIGHTED BY THE YELLOW ARROWS.  















TABLE 9 SYSTOLE AND DIASTOLE COORDINATES FOR THE LEFT CORONARY ARTERY IN 5 
HEALTHY VOLUNTEERS (V). THE NET TRANSLATION IS A DIFFERENCE BETWEEN THE SYSTOLIC 
AND DIASTOLIC POINTS IN THE 3 SPATIAL DIRECTIONS, X, Y AND Z. THE MOTION IS A VECTOR 
QUANTITY IN MM.  
 Systole coordinates Net Translation Motion Diastole coordinates 
V X Y Z X Y Z mm X Y Z 
1 









24.7 -46.36 -14.94 
2 









13.04 -38.3 -45.68 
3 









13.87 -18.06 24.95 
4 









15.95 -55.12 -33.88 
5 



























1 5 . 1 . 1  C i r c u m f e r e n t i a l  c h a n g e :  v o l u n t e e r s  
 
The average circumferential change in the aorta between systole and diastole by volunteer 
was 7.9%. Circumferential change by location along the aorta by volunteer is shown in 
Figure 66 along with a mean change for each location. As can be seen, almost uniformly, 
overall the greatest change in circumference occurred at the left coronary artery and the 
least in the descending aorta.  The mean change in circumference decreased along the 
length of the aorta. This is likely due to the relative rigidity of the descending aorta due to 
fixation to the spine and the tethering effect of the intercostal arteries. Subject 4 was an 




FIGURE 66 PERCENTAGE CIRCUMFERENTIAL CHANGE ALONG THE AORTIC LENGTH BY 
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1 5 . 1 . 2  C i r c u m f e r e n t i a l  c h a n g e :  p a t i e n t s  
 
For the dissection patients the true and false lumen changes were plotted according the 
cardiac phase. 
 
15.1.2.1 Patient A 
 
Figure 67 and Figure 68 for patient A shows a trend for the true lumen to expand in systole 
and collapse in diastole. The false lumen collapsed in systole for all locations except in the 
region of the descending aorta at the level of the 1st and 5th intercostal arteries. Here the 
false lumen was overall larger in size than the true lumen at both locations and furthermore it 
increased in circumference in the systolic phase. The false lumen at the level of the LSCA 
remained approximately the same. These results are shown in Table 10.   
Although the TL at 1st COA in systole was 40% smaller than the false lumen, in diastole this 
was 53% smaller. In systole at the 5th COA the TL was 20% smaller and in diastole it was 
30% smaller. The largest change in circumference was seen in the TL in systole at the level 
of the 1st COA which increased by 30%. 
 
 











FIGURE 68 DISSECTION PATIENT A. THE MODELS ON THE LEFT SHOW THE TRUE AND FALSE 
LUMENS CHANGES BETWEEN SYSTOLE AND DIASTOLE. TRUE LUMEN IS SHOWN IN BLUE, FALSE 








































TABLE 10 PATIENT A CIRCUMFERENTIAL CHANGE AND THEREFORE MOTION OF THE INTIMAL 






















LCCA TL 64.7 67.8 3.1 
-7.5% -7.9% 
LCCA FL 60.2 59.9 -0.3 
LSCA TL 56.1 60.6 4.5 
10.9% 2% 
LSCA FL 63 62.6 -0.4 
1st COA 
TL 




80.2 81.5 1.3 
5th COA 
TL 
49.4 54.5 5.1 
30% 13.2% 
5th COA 













15.1.2.2 Patient B 
 
For patient B, there was a trend for the TL to expand in systole and collapse in diastole 
except for at the region of the 1st intercostal artery where the TL remained the same (Figure 
69, Figure 70) The largest change of any kind was seen in the LSCA FL which was 
compressed by 28% in systole. The LSCA FL in diastole is 31% smaller than the LSCA TL 
and in systole the FL collapses significantly, the TL more than doubling in size. These results 
are shown in Table 10.  
 
 




































FIGURE 70 DISSECTION PATIENT B. THE MODELS ON THE LEFT SHOW THE TRUE AND FALSE 
LUMENS CHANGES BETWEEN SYSTOLE AND DIASTOLE. TRUE LUMEN IS SHOWN IN BLUE, FALSE 
IN PINK. THE FIGURES TO THE RIGHT SHOW THE OVERALL AORTIC CHANGES BETWEEN SYSTOLE 
AND DIASTOLE.  
 
TABLE 11 PATIENT B CIRCUMFERENTIAL CHANGE AND THEREFORE MOTION OF THE INTIMAL 




























 LSCA  
FL 
62.9 45.5 -27.7 
1st COA 
TL 




 1st COA 
FL 
59.6 63.1 5.8 
5th COA 
TL 




 5th COA 
FL 
76.1 78.5 3.2 




1 5 . 1 . 3  A o r t i c  s t r a i n :  h e a l t h y  v o l u n t e e r s  
 
As seen in the healthy volunteers, the mean longitudinal strain experienced was maximal in 
the aortic arch at 13.2%, 4.2% in the ascending aorta and -1.5% in the descending aorta. 
The circumferential strain at each chosen location was highest at the level of left coronary 
artery and lowest at the distal descending aorta at 6.3% (Figure 71). Finally the mean 
volumetric strain for the ascending aorta was in the region of 24%, 29% at the arch and 
16.7% in the descending aorta. Figure 72 shows the changes in the aortic strain by location 






















FIGURE 71 HEALTHY SUBJECTS STRAINS. TOP: LONGITUDINAL STRAIN, 
CENTRE: CIRCUMFERENTIAL STRAIN AND BOTTOM: VOLUMETRIC STRAIN, 
GREY BARS INDICATE THE STANDARD DEVIATION AND THE MEAN VALUES ARE 
SHOWN IN THE GREY CIRCLES. 
 
 





FIGURE 72 AORTIC STRAIN AS MEASURED IN DIFFERENT SEGMENTS OF THE AORTA DURING 
DIASTOLE AND SYSTOLE. VOL= VOLUMETRIC STRAIN, CL= CENTRELINE (LONGITUDINAL) 
STRAIN OF NOTE THE ARCH OF THE AORTA (AA) DEMONSTRATES THE LARGEST VOLUMETRIC 
AND CIRCUMFERENTIAL STRAIN. CONVERSELY, THE DESCENDING AORTA (DA) EXPERIENCES A 











1 5 . 1 . 4  A o r t i c  s t r a i n :   d i s s e c t i o n  p a t i e n t s  
 
15.1.4.1 Patient A 
 
The geometry and results for patient A are shown in Figure 73.  Volumetric and longitudinal 
deformations are shown on the left and the image reslices with the aortic circumference at 
each branching location on the right. 
Patient A demonstrated a volumetric strain of 32% in the AAo, 11.2% in the TL and 7.6% in 
the FL at the level of the arch and a strain of 44.2% in the TL of the DA. The FL of the DA 
showed a compressive or negative strain of 7.4%.  
 
The longitudinal strain in the AAo (+13.6 %) was larger than that the mean strain observed in 
the healthy subjects. A compressive longitudinal strain was observed in the AA (-5.1 % in the 
TL and -5.6 % in the FL). In the DA, the FL experienced a positive longitudinal strain (+12.8 
%) while the TL experienced a compressive strain (-1.3 %). Circumferential strain was found 
to be within the same range as the healthy subjects in the AAo. In the dissected regions of 
the AA and DA large circumferential strain were noted.  
 
15.1.4.2 Patient B 
 
The geometry and results for patient B are shown in Figure 74. Volumetric and longitudinal 
deformations are shown on the left and the image reslices with the aortic circumference at 
each branching location on the right. 
Patient B also demonstrated significantly greater volumetric strain in AAo (+19.5%) than in 
AA (TL: +1.6 % FL: -11.9 %). There was a positive volumetric strain in the DA (TL: +6.6 % 
FL: +8.0%). A positive longitudinal strain was seen in the AAo (+19.5 %) Longitudinal strain 
was compressive in the AA TL (-2.3 %) and a positive strain was seen in the FL (+15.7 %) 
(although this section of FL only represents 3.5 % of the total AA volume in systole). In the 




DA the TL demonstrates a negligible longitudinal strain (0.1%) while the FL saw a +1.8% 
strain. 
Circumferential strains observed in the AA at D.InoA (3.9%) and LCCA (4.1%) are 
significantly lower than those seen in the AAo at LCoA (14.2 %) and P.InoA (7.1%). The TL 
expansion was seen to have a significant influence on the FL, causing it to collapse in places 
such as at the LSCA where a large compressive circumferential strain (-23.8%) was 


















FIGURE 73 PATIENT A AORTIC STRAIN AND MORPHOLOGICAL CHANGES BY LOCATION. THE 
PANEL ON THE LEFT MIDDLE SHOW SEGMENTATIONS AND CALCULATED VOLUME (VOL) AND 
LONGITUDINAL (CL) STRAIN IN DIASTOLE AND SYSTOLE. THE PANEL ON THE RIGHT SHOWS THE 
IMAGE RESLICES AT THE CHOSEN POINTS OF INTEREST SHOWING VESSEL CONTOUR 

















FIGURE 74 PATIENT B AORTIC STRAIN AND MORPHOLOGICAL CHANGES BY LOCATION. THE 
PANEL ON THE LEFT MIDDLE SHOW SEGMENTATIONS AND CALCULATED VOLUME (VOL) AND 
LONGITUDINAL (CL) STRAIN IN DIASTOLE AND SYSTOLE. THE PANEL ON THE RIGHT SHOWS THE 
IMAGE RESLICES AT THE CHOSEN POINTS OF INTEREST SHOWING VESSEL CONTOUR 


















16.1 Follow up study  
 
Currently, the main criteria that prompt intervention in chronic dissections are size (>5.5.cm), 
rapid growth (>1cm/y), the presence of complications such as organ malperfusion the 
presence of symptoms such as pain. The follow up currently for stable dissection patients in 
the UK is by CT scanning, and this occurs on an annual basis.  
Although only three patients underwent yearly follow up, simulation results from only one 
have been developed. Nonetheless, just evaluating the differences in geometry between the 
three patients gives an indication of how each patient presents a unique pathological process 
and problem. Lumping these to fit a one-size-for-all management strategy seems 
inadequate. An individualized approach tailored to the patients requirements and based on 
the patient’s geometry and haemodynamics would be more relevant and more 
physiologically accurate whereby decisions to intervene are based on haemodynamic 
parameters and dynamic aortic morphology rather than Patient 1 underwent yearly follow up 
as well as a CFD simulation to assess the changes in aortic haemodynamics from baseline 
to the follow up. The main morphological change that was observed in this patient was a 
healing of tear 4 in the infradiaphragmatic region. Nonetheless there was no change in the 
volume of thrombus albeit no change in the size of the aorta of the false lumen either. This 
means that over one year, the false lumen still remains patent and still has flow as seen on 
MRI.  
The simulation results for patient 1 were interesting. These showed that at baseline the 
mean pressure in the aorta was higher (over 100mmHg) compared to 97mmHg in 2014. 
Around the area of tear 1, there was turbulent high velocity flow but the actual false lumen 
had low flow, albeit a high pressure. This may represent a blind pressurized sac. 




Interestingly this area in 2014 was still pressurised with a low flow suggesting that the blind 
sac theory is probably correct and that there may be potential for false lumen growth here. 
Additionally, all tear areas showed turbulent flow as would be expected, except for the region 
of tear 4, which already showed low flow and pressure at baseline. It is therefore not 
surprising that a year on this tear had healed and was no longer visible on the CAD model 
derived from the follow up imaging data.  
Already with a change in local attitudes, clinical follow up with CT scans seems to be losing 
favour and instead MRI scanning seems to be gaining popularity and momentum. Of course 
availability of scanners, of trained medical staff to interpret the scans, and the time taken to 
acquire images all need to be taken into consideration from a diagnosis point of view where 
CT still trumps MRI. However, it is not before long, that the use of MRI even for diagnosis will 
become commonplace.  
CFD and simulation have the ability to provide clinicians with a wealth of data that can be 
applied to daily practice. By starting with image data a model is built which is then divided 
into many smaller parts or subdomains to numerically solve the equations of motion for a 
fluid.  The result provides parameters such as pressure and wall shear stress which are 
difficult to measure in vivo. These derived parameters are important in understanding 
diseases pathology, and progression to therefore allow for a tailor made approach to 















17.1 Black blood study 
 
In this study the potential utility of T2PSIR and T2IR sequences in imaging of the thoracic 
aorta, with respect to scan time, apparent CNR, image sharpness and a qualitative visual 
scoring was undertaken in eleven volunteers and two patients with aortic dissection. The aim 
of this study was to devise optimum sequences for black blood imaging to accurately 
investigate morphology of the aortic intimal flap in dissection.  
The T2PSIR sequence was shown to be superior with respect to image quality as assessed 
by CNR, sharpness and visual scores, although the scan time was longer than T2IR. The 
improved image quality is likely due to the ability of T2PSIR to provide optimal blood-to-
vessel wall contrast for any heart rates, as well as the increased signal that is obtained by 
performing the non-selective inversion pulse every other cardiac cycle. Based on these 
results we have found T2PSIR to be the more favourable approach, the increased scan time 
notwithstanding.  
In this study, the potential feasibility of using the T2PSIR sequence in patients with aortic 
dissection to visualize the intimal flap as well as the location of tears was also demonstrated. 
Visual comparison with CT in the dissection patients shows good agreement.  
Although slow flowing blood can be adequately suppressed using T2IR or T2PSIR, the pilot 
study indicated that rapid blood flow during the application of the T2 prepared pulses leads to 
flow-artefacts. Furthermore, by positioning the T2-prep pulses in a cardiac phase with low 
flow, immediately after the R-wave, these flow artefacts can be minimized.  
The main drawback of the T2PSIR sequence is the increased scan time compared to T2IR 
which augments the susceptibility to respiratory motion induced artefacts due to respiratory 




drift or irregular breathing. The use of respiratory gating with an end-expiratory 5 mm window 
reduces respiratory motion artefacts at the expense of further prolonging the scan time.  
Highly efficient respiratory motion compensation techniques have been proposed for 
coronary magnetic resonance angiography (MRA) to directly track and compensate for bulk 
respiratory induced motion of the heart (92–94). Similar techniques may be applicable to 
aortic T2PSIR to reduce the total scan time by allowing for data acquisition throughout the 
whole respiratory cycle. Additional scan time reduction may be obtained using compressed 
sensing which allows for image acceleration beyond what can be achieved with conventional 
parallel imaging, which was employed in this study (95). 
Several negative prognostic indicators have been identified in aortic dissection. These 
include tear location (proximal tears fare worse than distal ones), size (larger tears are 
associated with a worse outcome than smaller tears) number of entry tears (one is worse 
than many) and partial thrombosis of the false lumen. (33,39,42,96,97) As far as the latter is 
concerned, ongoing perfusion of the false lumen without an exit tear leads essentially to a 
blind pressurized sac and aortic dilatation.  
For this reason, a detailed evaluation of the tear morphology and geography may facilitate 
patient specific management, including tailor-made follow up as dictated or indeed 
intervention (33,42,79,96–99). Based on the promising initial results reported here, further 
studies are warranted in patients with aortic dissection using T2PSIR techniques. The scope 
of future work using these techniques should focus on the utility of the T2PSIR in imaging of 
aortic dissection, where subtle anatomical features of clinical importance such as tear 
location and anatomy may well be more accurately visualized compared to conventional CT 
standards.   
 
 








18.1 Dual phase study 
 
The aorta is a complex organ with complex biomechanical properties. Aortic pulsatility and of 
its associated side branches along with the rapid change in motion direction throughout the 
cardiac cycle may play a significant role in the management of aortic pathologies. It therefore 
follows that complex forces are generated and exerted onto stent grafts thereby resulting in 
graft migration and failure. Therefore, the ideal selection of a graft for a particular patient or 
pathology is vital. (100,101) 
In as much as the aorta being a complex structure, aortic dissection represents an even 
more intricate morphological and physiological environment. In biomechanical terms, the 
dissection results in a separation of the elastic layers of the aortic wall occurring when the 
haemodynamic loads exerted on the aorta exceed the forces holding the aortic layers 
together. (102) 
The intimal flap is but a few millimetres thick and can be expected to experience vast motion 
throughout the cardiac cycle. This can in turn lead to dynamic obstruction of the true lumen 
with each heartbeat resulting in branch vessel ischaemia. (103) Although this motion is 
difficult to assess via a static 2D imaging modality like CT scanning it has been done by 
previous groups. (104–106) The use of ECG gated CT aortography reduces artefacts and 
provides functional assessment, albeit with a higher radiation dose. Ganten et al showed that 
the true lumen collapsed by up to 29% in some cases. This of course can have a significant 
impact on visceral ischaemia. Other groups’ studies have investigated the aortic motion at 
the level of the aortic root abdominal aorta and the ascending aorta utilising CT scanning. 
(100,106–108) and have all  indicated the variability of aortic motion from beat to beat and its 
resultant mechanical effects not just on therapeutic endografts placed in these regions but 




also the native aorta leading to additional stress. Displacement of the aortic root during the 
cardiac cycle has been shown to range from 0-22mm in patients with cardiovascular 
diseases. Those with aortic regurgitation exhibit greater displacement and those with left 
ventricular hypokinesis show the opposite trend. Additional work has also indicated the 
increase in mechanical stresses in the aortic wall as a result of aortic root motion, perhaps 
offering an explanation for the tear location and orientation as seen in aortic dissections. 
(107,109) 
The current dual phase study described has several advantages over the CT scan studies. 
Firstly, there was no associated radiation. Additionally accurate tracking of cardiac motion 
was performed using a cine scan and PC-MR flow data. Additional functional data such as 
velocity and flow were also readily obtainable.  
The study focussed on investigating the utility of dual phase aortic imaging to understand the 
motion and strain on the aorta during the cardiac cycle in normal healthy volunteers and then 
to investigate the effects in a patient with aortic dissection. 
Study of the healthy subjects demonstrated that the ascending aorta was a mobile structure 
demonstrating a mean longitudinal strain of 4.2%, and a volumetric strain of 24%. For each 
fixed location the mean circumferential strain was approximately 8%. 
The arch was a more mobile structure than the ascending aorta, demonstrating longitudinal 
strain in the order of 13% and a volumetric strain of 29%. It is possible that the supra-aortic 
branches serve to restrain the longitudinal motion of the aorta. Finally, the descending aorta 
in comparison was rather fixed, demonstrating a volumetric strain of 16.7% and a 
compressive strain of -1.5%.  This compressive strain can be explained by the relative 
fixation of the descending aorta to the spine thereby attenuating its longitudinal motion. 
Longitudinal and circumferential strain both contribute to volumetric strain which was found 
to be significantly less in the AAo than in the AA. One reason for this may be the existence of 
the visceral branches, particularly the ascending vessels. The DA on the other hand is 
relatively fixed to the spine, as well as being tethered to the ligamentum arteriosum and 




attenuates lateral aortic motion from longitudinal strain and a comparable circumferential 
strain contribution. The AAo is like a rigid body deformation as there are no branching 
vessels between the coronaries and the innominate artery thereby resulting in lower 
longitudinal strain and the primary contribution to volumetric strain being circumferential 
changes. The AA shows a greater volumetric change as there is a larger contribution from 
longitudinal strain and a similar contribution from circumferential strain. 
Results from patients having been treated for TAAD with a residual Type B component were 
interesting. Here the ascending aorta demonstrated higher strain than in healthy subjects 
perhaps reflective of the material properties of the Dacron graft used to repair the ascending 
aorta. Additionally the arch seemed to exhibit lower strain than the healthy subjects perhaps 
indicative of the stress of the graft proximally and the relatively fixed descending thoracic 
aorta distally. Of note, patient A seemed to have an excessively long Dacron graft, which 
seemed to be folding over and causing an apparent stenosis. There is a likely greater 
pressure differential in this area, with a large pressure proximal to the stenosis and a lower 
pressure distal to it. This may result in a lowered volumetric strain distally in the distal 
ascending aorta or the arch. This patient also had suspected Marfan pathology, which may 
again affect the strain distribution. Clearly the aorta distal to the Dacron repair would have an 
abnormal infrastructure due to the pathology and this could lead to a lowered strain in this 
area.  
Patient B seemed to have a smaller stenosis in the region just proximal to the P.InoA again 
leading to a similar distribution of strain as for patient A. A final observation in these two 
patients is also the increased age compared to the healthy volunteers. (Patient A 46, B 53 at 
the time of the scan) and age related biomechanical changes occur in the aorta, with 
reduced distensibility affecting the arch the least. Both patient A and B demonstrated 
compressive or negligible longitudinal strains in the DA. TL and a positive strain in the DA FL 
This is due to the geometry of the dissection. In both cases the FL is on the outer curvature 
of the arch. During systole, the TL enlarges, which in turn imposes on the FL causing it to 
distend resulting in a tensile longitudinal strain. It is possible that a false lumen on the inner 




curvature may experience a compressive longitudinal strain. Clinical observations noted 
support for this hypothesis, suggesting a false lumen situated the outer curvature have 



























19.1 Proposed patient pathway for long term 
management of acute, residual (chronic) Type B 
dissections 
 
As an insight into the direction of personalized medical care, this work demonstrates the 
potential utility of the combination of non-ionizing functional imaging modalities and CFD 
methodology into clinical practice.  
Based on results from this work, it would be feasible to consider that CFD has an important 
role to play in the management of aortic dissection. Although patients presenting with an 
acute TAAD will always be excluded from such pathways due to the urgent nature of the 
intervention required however, patients with acute TBAD are a different cohort.  
Dilatation of the false lumen affects 50% of patients over 5 years and survival ranges from 
50-82%. Complete thrombosis is associated with a better survival than a fully patent false 
lumen but partial thrombosis has the worst outcomes. Although the management of 
uncomplicated TBAD seems to be at present conservative, randomized controlled trials have 
indicated the utility of stent graft use in stable aortic dissection. There are only 2 prospective 
randomized controlled trials in uncomplicated dissection the ADSORB for acute dissections 
up to 14 days and the chronic INSTEAD trial looking at dissections between 14 days to -1 
year. The Investigation of stent grafts in aortic dissection trial (INSTEAD) is the first 
randomized controlled trial to compare best medical therapy (BMT) with stent graft 
placement in addition to best medical therapy. This trial was designed to compare and 
evaluate the effects of stent graft placement in Type B patients who would have otherwise 
been conservatively managed with medication alone.   




Although the 2-year results did not show a significant difference in outcomes (survival, 
vascular, and progression) aortic remodelling and stability were seen in the overwhelming 
majority of cases (90%) treated with best medical therapy and stent graft placement. 
Additionally there was up to a 20% crossover from the BMT group to the stenting or surgery 
group due to false lumen expansion or other late complications.  
The amended follow-up study, INSTEAD-XL includes 5-year follow up. In this cohort, the 
BMT group experienced further ongoing complications and fatalities whereas the stented 
patients had a stable long term, course and no fatalities up to 5 years. The investigators of 
INSTEAD postulated that the so called ‘uncomplicated’ TBAD are actually not so 
uncomplicated in the years following dissection, and these patients treated conservatively 
often had further false lumen expansion and aortic rupture. Additionally, these patients 
deemed stable initially seemed to die suddenly, indicating perhaps that the mechanism of 
death was due to aortic rupture and this stresses the fact that the current monitoring 
programme is not able to detect the at risk patient, and more importantly, a static 
measurement of aortic diameter is not an indicator of safety. Aortic remodelling and healing 
to allow for morphological correction are crucial to providing stability and stent graft 
placement is superior at this than best medical treatment alone. (27) 
Optimal medical treatment is essential in the acute setting, not forgetting that the 
haemodynamic insult that results in a weakened aorta is elevated systolic and mean arterial 
blood pressure. Equally important in patients deemed fit for discharge without intervention is 
the regular monitoring of blood pressure and a tight control keeping the pulse pressure and 
heart rate low, as these are factors that propagate the dissection. (111) 
These insights suggest that the stable dissection patient is actually not so stable as thought 
and an detailed understanding of the intra-aortic morphology and haemodynamcis on a 
personalized basis will be provide accurate information to best manage each patient. Aortic 
remodelling is the key to stabilizing the dissected aorta offering healing and realignment of all 




layers of the aorta. So far data suggest that dissection is never safe under BMT alone for 
uncomplicated TBAD. 
The ADSORB trial, (Acute Dissection: Stent graft OR Best medical therapy aimed to 
compare freedom from events such as : 
1. Incomplete or no false lumen thrombosis in any part  of the false lumen  
2. Aortic dilatation of greater than 5cm or the max diameter of the descending aorta 
>55mm.  
3. Aortic rupture on CT 
In this trial, 61 patients were randomized in 17 European centres from Dec 2009-Dec 2010. 
There were 29 patients in the BMT plus stent group and 30 in the BMT group alone.  
Unpublished results (at the time of writing) of the trial demonstrated a statistically significant 
greater freedom from the composite end point at the end of the 1-year study in the BMT plus 
TEVAR group as compared to those in the BMT alone cohort (57% vs 3%; P <.001). One 
reason for this is that there was a significant difference in false lumen thrombosis between 
groups, as no significant difference was seen in the aortic dilatation and rupture components 
of the composite end point. Secondary aortic remodelling end points were improved in the 
BMT plus TEVAR group, with a statistically significant larger true lumen and smaller false 
lumen, and generally a smaller overall aortic diameter, as compared to the BMT alone 
cohort. 
It is important to realise that the composite end point does not provide clinically useful 
information, which can steer clinical decisions.  
Another group has published long-term follow-up data for endovascular repair of acute 
complicated TBAD and here over 20% of patients required additional (one or more) 
adjunctive procedures in addition to the original TEVAR, to treat malperfusion as a result of 
the dissection. Over the follow up period (median 34 months) 26% of patients required re-
intervention for a number of reasons although there was no difference in survival between 




those who required re-intervention and those who did not. This itself highlights the true 
complexity of this condition compared to TEVAR for a more ‘stable’ pathology such as 
aneurysm.(110) The high re-intervention rate itself is an indication that lifelong aortic 
surveillance by an experienced aortic centre is undertaken to identify and treat 
complications.  
Based on these observations and studies, the potential utility of CFD in the preoperative 
work up and the post-operative result can be imagined. A proposed patient pathway is shown 
in Figure 75. 
Patients with an acute TBAD would undergo MRI scanning if stable, to ascertain flow data 
from PC-MRI.  CT image data will provide the morphological basis for development of a CAD 
model although strictly speaking the MRI can suffice alone. Combining the two using 
cardiovascular modelling software like CRIMSON would lead to a patient specific model of 
the dissection. Next, using flow data from the patients MRI and non-invasive BP 
measurements taken during the MRI scan one has the boundary conditions to inform the 
CAD model. This will then give an indication of real time intra-aortic haemodynamics, better 
informing us about the dynamic behaviour of the dissection. Additionally MRI methods as 
described can be relied upon to give detailed tear information on morphology. Dual phase 
scanning can give an indication of aortic strain. All these methods combined aim to give a 
dynamic assessment for patients with a TBAD rather than relying on static image data or 
dimension change that is currently employed in the treatment planning for these patients.       
 
FIGURE 75 PROPOSED PATIENT PATHWAY FOR TBAD PATIENTS.  








20.1 TEVAR Study 
 
Inclusion of invasive haemodynamic pressure wire readings for three patients was not given 
approval in this body of work. This was a major setback to the study as it was aimed at 
providing the first in vivo confirmation of simulation results for aortic dissection. Despite 
retrospective ethical approval the inclusion was not permitted. In addition to this major 
setback, a change in the local surgical practice, led to a shift away from TEVAR for TBAD 
unless there were complications or haemodynamic instability. Although several other 
patients were identified on the wards, none underwent TEVAR and therefore no further 
recruitment into this arm of the study was possible.  
 
20.2 Follow up study 
 
The aim of follow up study was to image patients at a one year interval from their original 
recruitment date and develop models ready for simulation. Several changes occurred during 
this period. The MRI protocol initially developed was deemed too long with not all sequences 
providing relevant information. This protocol was therefore modified. The major limitation of 
performing the MRI scans on these patients was degradation in image quality due to 
individual patient factors such as arrhythmias or discomfort and therefore motion artefacts 
several scans had to be abandoned. Model development proved to be quite laborious, as the 
development of a new in house package, CRIMSON required several bug fixes and updates. 
The software used prior to the implementation of CRIMSON (SimVascular) was slow and 
obsolete and therefore all models had to be rebuilt in CRIMSON. 




Time wise it took several weeks and quite frequently months develop a single model that 
seemed accurate, as previous model building had been done for a simple tubular structure 
without the addition of a complex dissection flap.  
All three dissection patients with a one year follow up had extremely challenging geometries 
which took months to develop. Further problems were encountered when the blending and 
meshing operations took place as the complex geometry meant a workable model required 
several iterations. Unfortunately for one patient the (patient 3) initial and follow up models 
were extremely tricky¸ and despite best efforts a workable meshed model was unable to be 
developed.  
Finally, the simulation process was time consuming and expensive, thereby limiting the 
number of simulations to be developed. The first hurdle was to extract usable PC-MRI data 
for flow and velocity measurements. This was tricky in the regions of the true and false 
lumens. Flow patterns in the false lumen were difficult to interpret due to turbulence.  
Previous work within the lab had suggested developing coarse meshes initially to define 
workable parameters for each model as development of a fine mesh although led to a more 
physiologically correct interpretation of haemodynamics it was expensive and mistakes in the 
mesh had financial implications. For this reason simulation was performed using a coarse 
mesh in just one patient. 
 
20.3 Black blood 
 
A fundamental limitation of the T2 prepared inversion recovery sequence is that the T2prep 
prepulse (in general 30-50ms in duration) has to be performed during a cardiac phase with 
low flow to ensure homogeneous blood suppression, which may be difficult in patients with 
high heart rates. However, a phase contrast scan can be performed prior to the T2IR or 
T2PSIR to measure blood flow to ensure that the T2prep pulse is performed in the phase with 
lowest flow.  




The negative factor associated with the T2PSIR sequence is the length of time it currently 
takes to acquire scans. Clearly in the clinical setting it would not be feasible to undertake 
such long scans. Further optimization however will lead to quicker data acquisition.  
 
 
20.4 Dual phase 
 
The main limitation of the dual phase study was realising that the cardiac phases of systole 
and diastole were only clearly visualised when a cine scan was performed and the state 
contraction or relaxation were physically sought for by eye. This meant that previous scans in 
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A1 Patient invitation letters:  pressure wire study 
 
 Date: Feb 2014 
 Version: 2 
Dear Mr. / Mrs. 
You have been informed by the vascular surgery team that you will benefit from an operation 
to manage your aortic dissection. 
To help us understand this condition in more detail and improve our treatment options in the 
future, I am writing to invite you to consider participation in a study whilst you are undergoing 
your planned operation. 
I have enclosed an information leaflet detailing the study along with my contact details. If you 
are interested in participating, I would be grateful if you contact me by completing and 
posting the enclosed stamped reply slip, or by phone, email or text, details below.  
Thank you in advance, for your time and efforts in helping us understand this condition better 
and enabling us to improve our service. 
Many thanks, 
Yours sincerely, 
Dr. Alia Noorani  
On behalf of Prof. Taylor and the research team,  
Write: Division of Imaging Sciences  
3rd Floor Lambeth Wing, 
St. Thomas’ Hospital,  
London  
SE1 7EH 
Phone or Text: 07715802408 
Email:  alia.noorani@kcl.ac.uk 
 




A1 Patient invitation letters – MRI study 
	  
 
Date: Feb 2014 
Version 2 
Dear Mr. / Mrs.  
Aortic dissection is a complex condition and we are investigating the use of magnetic 
resonance imaging (MRI) scans to help us understand it in more detail, with the potential to 
improve our treatment options in the future. 
The enclosed information leaflet details the study and explains the MRI procedure.  
If you are interested in participating, I would be grateful if you would contact me by 
completing and posting the enclosed stamped reply slip, or by email, phone or text on the 
number below.  We will reimburse your travel costs to and from the hospital.  
Thank you in advance, for your time and efforts in helping us understand this condition better 
and enabling us to improve our service 
Many thanks 
Yours sincerely 
Dr. Alia Noorani  
On behalf of Prof. Taylor and the research team,  
Write:  
Division of Imaging Sciences  
3rd Floor Lambeth Wing, 
St. Thomas’ Hospital,  
London  
SE1 7EH 
Phone or Text: 07715802408 
Email:  alia.noorani@kcl.ac.uk 
 




A2 Patient information – invasive study 
PARTICIPANT INFORMATION SHEET 
 
A study of haemodynamics in aortic dissection 
 
PROTOCOL REFERENCE NUMBER: 14/LO/0286 
VERSION NUMBER: 2 
DATE: February 2014 
 
We would like you invite you to take part in our research study.  Before you decide we would 
like you to understand why the research is being done and what it will involve for you.  
Please take time to read the following information carefully. Talk to others about the study if 
you wish. The research doctor (name below) will go through the information when they meet 
with you. 
  
Part 1 tells you the purpose of this study and what will happen to you if you take part.   
Part 2 gives you more detailed information about the conduct of the study.  
 
Ask us if there is anything that is not clear or if you would like more information.  Take time to 










1. What is the purpose of the study? 
Aortic dissection is a tear in the lining of the main artery from the heart. This can happen for a 
number of reasons, commonly due to high blood pressure. Typically, patients experience 
severe chest pain. When a tear occurs, a second false channel or lumen for blood flow can 
develop. Blood flow can be diverted into this false channel and can affect the blood supply to 
other vital organs. The management of dissection depends on the location of the tear in the 
aorta (upper or lower part) and the presence of any other complicating factors.  
Patients with complications are offered an operation, called a stent graft procedure whereby 
a mesh-tube is inserted into the aorta via the groin blood vessels. This provides stability to 
the aorta and seals the tear. Some patients have poor outcomes after their dissection and we 
need to understand why this is the case. High blood pressure in the false lumen is thought to 
be an important factor, although this has not been proven as yet. In this study we intend to 
take accurate blood pressure readings using a specialized catheter while you are having 
your stent graft procedure. 
2. Why have I been chosen? 
You have been chosen because you have an aortic dissection, which is being treated with a 
stent graft operation.  
3. Do I have to take part? 
No.  It is up to you to decide whether or not to take part. Your clinical team (vascular surgery) 
will describe the study. If you agree to take part, a member of the research team will 
approach you on admission, to go through this information sheet, discuss any questions and 
ask you to sign a consent form. You are still free to withdraw at any time and without giving a 




reason.  A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard or type of care you receive.  
4. What wil l  happen to me if I  take part? 
Patients enrolled in this study will be consented by the clinical vascular surgical team for their 
stent graft operation. Additionally the research team will seek your consent for this research 
study. With your consent, we would invite you to undergo an MRI scan prior to the operation 
and plan to take pressure measurements from your aorta whilst you are undergoing your 
stent graft procedure. We anticipate will add a further 5 minutes to the overall operation.  
5. What do I have to do? 
You need read this information leaflet and decide if this study may be of interest to you. In 
addition, if you are part of any other experimental studies you should make this known. If you 
would like to take part, please contact Miss Alia Noorani, (co-investigator) by completing and 
returning the enclosed reply slip by post, by email on al ia.noorani@kcl.ac.uk or by phone 
or text on 07715802408. 
6. What are the side effects of any treatment received? 
There is a small (less than 0.5%) chance that the pressure catheter causes damage to the 
aorta. It is important to remember that the catheter itself is small and is commonly used to 
detect problems in the blood vessels of the heart, which are extremely fragile. If any damage 
to the aorta occurs, it will be treated in the same way as originally planned, i.e with a stent 
graft, as this effectively seals the tear.  
There is also a theoretical, very small, less than 0.1% chance of stroke associated with the 
pressure wire. It is important to remember that the stent graft procedure itself is associated 
with a risk of stroke (less than 5%) and that this risk is outweighed by the benefits of the 
operation to treat the dissection.  




Because your operation is minimally invasive (like a key hole procedure), it does not involve 
big incisions or cuts on the body. Therefore, in order to be able to perform the procedure, X-
ray guidance is used to inform the surgeons the exact location of the tear in the aorta and 
where it is ideal to place the stent graft. During the operation, you will be exposed to X-rays 
as routine and the research study will add a further 5 minutes to the exposure. We all have a 
1 in 3 chance of getting cancer, even if we never have an X-ray. It is important to consider 
that these extra X-ray examinations still represent a very small addition to this underlying risk 
from all causes.  
7. What are the other possible disadvantages and risks of 
taking part? 
The only disadvantage as mentioned above is additional, short X-ray exposure during your 
existing stent graft procedure, although the extra exposure represents a very a very small 
additional risk. 
8. What are the possible benefits of taking part? 
We cannot promise that the study will help you, but the information we gain from this study 
will potentially help us improve the treatment of patients with aortic dissection in the future. 
9. What happens when the research study stops? 
Results from this study will then be used to understand the importance of pressure in the 
false lumen and help target our management of patients who may be at greatest risk at the 
time of their original presentation.  
10. What if  there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed.  




The contact details are:  
Miss Alia Noorani (Co-Investigator) 
Division of Imaging Sciences 
3rd Floor Lambeth Wing, 
St Thomas’ Hospital 
London 
SE1 7EH 
Telephone: Department of Imaging Sciences: 020 71885441 
Direct line:  07715802408   Email: alia.noorani@kcl.ac.uk 
11. Wil l  my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept confidential.  The 
details are included in Part 2. 
12.  Contact Details: 
For further information please contact:  
Miss Alia Noorani (Co-Investigator) 
Division of Imaging Sciences 
3rd Floor Lambeth Wing, 
St Thomas’ Hospital 
London SE1 7EH 
Telephone: Department of Imaging Sciences: 020 71885441 Direct line:  07715802408 





This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering participation, please 
continue to read the additional information in Part 2 before making any decision.





13.   What wil l  happen if I  don’t want to carry on with the 
study?  
This will in no way affect any further medical treatment you receive within the Trust.  
14.    What if  there is a problem?  
A - Complaints:  
If you have a concern about any aspect of this study, you should ask to speak with the 
researchers who will do their best to answer your questions (Miss Alia Noorani: 
07715802408). If you remain unhappy and wish to complain formally, you can do this by 
contacting the Patient Advice and Liaison Service (PALS) based at St. Thomas’ 
Hospital. Details are as follows: 
Visit PALS at:  
The Knowledge and Information Centre (KIC) 
Ground Floor, North Wing, St. Thomas’ Hospital.  
Timings: Monday- Friday 10am-12pm and 2pm-4pm.  
Tel: 020 7188 8801 / 020 7188 8803 
Fax: 020 7188 1651 
Email: pals@gstt.nhs.uk 
Write: Patient Information Team, KIC, Ground Floor, North Wing, St Thomas’ Hospital, 
Westminster Bridge Road, London SE1 7EH. 
 





B - Harm:   
In the event that something does go wrong and you are harmed during the research study 
there are no special compensation arrangements.  If you are harmed and this is due to 
someone’s negligence then you may have grounds for a legal action for compensation 
against King’s College London but you may have to pay your legal costs. The normal 
National Health Service complaints mechanisms will still be available to you.  
15. Wil l  my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential and anonymous. It may become necessary to access your hospital 
medical records.  
Access to data collected in the study will securely be held on computers with access 
restricted to members of the research team. It will be used to develop further studies, which 
will need to be approved by an ethics committee. Results may be used in presentations or 
publications, but they will be anonymous. Procedures for handling, processing, storage and 
destruction of data will be compliant with the Data Protection Act 1998. 
16.  Involvement of the General Practit ioner/Family doctor 
(GP)  
Your GP will be notified of your participation in the study. In addition, it will also be recorded 
in your hospital medical records.  
17.   Wil l  any genetic tests be done?   
No genetic tests will be done. 
18.   What wil l  happen to the results of the research study? 




It is hoped that the results of this study will be used to provide information for a larger study 
looking at non-invasive methods of pressure assessment. It is possible that the results will be 
published and presented both nationally and internationally. If this occurs, it will not be 
possible to trace individual patient data.  
19. Who is organising and funding the research?   
The research is being organised by King’s College London and by Guy’s and St. Thomas’ 
NHS Trust and is funded by the Royal College of Surgeons of England and Heart Research 
UK. The doctors conducting the research receive no direct funding for co-ordination of the 
study.  
20. Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been given a favourable review 
by the Bromley Research Ethics Committee.  
 
 
MAY WE THANK YOU FOR CONSIDERING TAKING PART IN 
THIS STUDY 
 
	   	  




A2 Patient information- MRI study 
 
PARTICIPANT INFORMATION SHEET 
 
A study of haemodynamics in aort ic dissection 
(MRI scans) 
 
PROTOCOL REFERENCE NUMBER: 14/LO/0286 
VERSION NUMBER: 2 
DATE: February 2014 
We would like you invite you to take part in our research study.  Before you decide we would 
like you to understand why the research is being done and what it will involve for you.  
Please take time to read the following information carefully. Talk to others about the study if 
you wish. The research doctor (name below) will go through the information when they meet 
with you. 
  
• Part 1 tells you the purpose of this study and what will happen to you if you take part.   
• Part 2 gives you more detailed information about the conduct of the study.  
 
Ask us if there is anything that is not clear or if you would like more information.  Take time to 









1. What is the purpose of the study? 
Aortic dissection is a tear in the lining of the aorta, which is the main artery branching from 
the heart. This can happen for a number of reasons, commonly due to high blood pressure. 
Typically, patients experience severe chest pain. When a tear occurs, a second false 
channel (or lumen) for blood flow can develop. Blood flow can be diverted into this false 
channel and affect the blood supply to other vital organs. The management of dissection 
depends on the location of the tear in the aorta (upper or lower part) and the presence of any 
other complicating factors.  
Some patients have poor outcomes after their dissection and we need to understand why 
this is the case. High blood pressure in the false lumen is thought to be an important factor, 
although this is not proven as yet. In this study we want to develop a non-invasive method of 
studying aortic pressures using MRI and computer simulation methods.   
2. Why have I been chosen? 
You have been chosen because you have an aortic dissection, which is being monitored with 
regular Computed Tomography (CT) (and / or MRI scans).  
3. Do I have to take part? 
No.  It is up to you to decide whether or not to take part. We will describe the study and go 
through this information sheet. If you agree to take part, we will ask you to sign a consent 
form. You are still free to withdraw at any time and without giving a reason.  A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard or type of care 
you receive.  
 




4. What wil l  happen to me if I  take part? 
Patients enrolled in this study will be asked to have a total of 3 MRI scans over a period of 1 
year. The scans will take about one hour each and we will check your most recent kidney 
function tests (via the hospital system or your GP). During the scan we may also site an 
intravenous cannula so a contrast agent (dye) can be given. We will reimburse your travel 
costs to and from the hospital.  
5. What do I have to do? 
You need to read this information leaflet and decide if this study may be of interest to you. In 
addition, if you are part of any other experimental studies you should make this known. If you 
would like to take part, please contact Miss Alia Noorani, (co-investigator), by completing and 
returning the enclosed reply slip by post, by email, on al ia.noorani@kcl.ac.uk or by 
phone or text on 07715802408.  
6. What are the side effects of any treatment received? 
MRI does not have any known adverse effects. If you have a pacemaker or other implanted 
metallic device or metallic foreign body we will ask you very specific questions about these 
before considering putting you in the MRI scanner. 
The contrast agent (dye) used for the MRI scan can potentially cause allergic reactions. A 
mild reaction such as nausea, headache or a temporary funny taste in the mouth can occur 
in one in a hundred people (1%). Severe reactions such as anaphylaxis are very rare 
(<0.00001%). 
 In patients with severe kidney impairment (defined as GFR<30 mL/min/1.73m2) there is a 
risk of a contrast-based reaction called nephrogenic systemic fibrosis (NSF) but this is very 
rare (<0.00001%). Administration of these agents is considered to be safe in patients without 
severe impairment of renal function. 




7. What are the other possible disadvantages and risks of 
taking part? 
It is important that you inform us if you are or could be pregnant.  
If you have private medical insurance you should check with the company before agreeing to 
take part in the study to ensure that your cover will not be affected. 
8. What are the possible benefits of taking part? 
We cannot promise that the study will help you, but the information we gain from this study 
will potentially help us improve the treatment of patients with aortic dissection in the future. It 
is however possible that other conditions you were not aware of will be discovered during the 
study. If this occurs then further follow up arrangements will be made. 
9. What happens when the research study stops? 
Results from this study will be used to understand the importance of pressure in the false 
lumen and develop a non-invasive method of studying these pressures. The overall hope of 
this project is to improve how to target and manage patients who may be at greatest risk at 
the time of their original presentation.  
10.   What if  there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed.  
The contact details are:  
Miss Alia Noorani (Co-Investigator) 
Division of Imaging Sciences 
3rd Floor, Lambeth Wing 




St Thomas’ Hospital 
London 
SE1 7EH 
Department of Imaging Sciences: 020 71885441 
Direct line:  07715802408 
Email: alia.noorani@kcl.ac.uk 
11.   Wil l  my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept confidential.  The 
details are included in Part 2. 
12.  Contact Details: 
For further information please contact:  
Miss Alia Noorani (Co-Investigator) 
Division of Imaging Sciences 
3rd Floor Lambeth Wing, 




Department of Imaging Sciences: 020 71885441 
Direct line:  07715802408 





This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering participation, please 
continue to read the additional information in Part 2 before making any decision.




PART  2 
13.   What wil l  happen if I  don’t want to carry on with the 
study?  
This will in no way affect any further medical treatment you receive within the Trust.  
14.    What if  there is a problem? 
A - Complaints:  
If you have a concern about any aspect of this study, you should ask to speak with the 
researchers who will do their best to answer your questions  
(Miss Alia Noorani: direct line 07715802408).If you remain unhappy and wish to complain 
formally, you can do this by contacting the Patient Advice and Liaison Service 
(PALS) based at St. Thomas’ Hospital. Details are as follows: 
Visit PALS at:  
The Knowledge and Information Centre (KIC) 
Ground Floor, North Wing, St. Thomas’ Hospital.  
Timings: Monday- Friday 10am-12pm and 2pm-4pm.  
Tel: 020 7188 8801 / 020 7188 8803 
Fax: 020 7188 1651 
Email: pals@gstt.nhs.uk 
Write: Patient Information Team, KIC, Ground Floor, North Wing, St Thomas’ Hospital, 
Westminster Bridge Road, London SE1 7EH. 
 




B - Harm:   
In the event that something does go wrong and you are harmed during the research study 
there are no special compensation arrangements.  If you are harmed and this is due to 
someone’s negligence then you may have grounds for a legal action for compensation 
against King’s College London but you may have to pay your legal costs. The normal 
National Health Service complaints mechanisms will still be available to you.  
15. Will  my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential and anonymous. It may become necessary to access your hospital 
medical records.  
Access to data collected in the study will securely be held on computers with access 
restricted to members of the research team. It will be used to develop further studies, which 
will need to be approved by an ethics committee. Results may be used in presentations or 
publications, but they will be anonymous. Procedures for handling, processing, storage and 
destruction of data will be compliant with the Data Protection Act 1998. 
16.  Involvement of the General Practit ioner/Family doctor (GP)  
Your GP will be notified of your participation in the study. In addition, it will also be recorded 
in your hospital medical records.  
17.   Wil l  any genetic tests be done?   
No genetic tests will be done. 
18.   What wil l  happen to the results of the research study? 
It is hoped that the results of this study will be used to provide information to develop a non-
invasive method of pressure assessment. It is possible that the results will be published and 




presented both nationally and internationally. If this occurs, it will not be possible to trace 
individual patient data.  
19. Who is organising and funding the research?   
The research is being organised by King’s College London and by Guy’s and St. Thomas’ 
NHS Trust and is funded by the Royal College of Surgeons of England and Heart Research 
UK. The doctors conducting the research receive no direct funding for co-ordination of the 
study.  
20. Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee to protect your interests. This study has been given a favourable opinion 
by the Bromley Research Ethics Committee. 
 
 
















A3 Research protocol- invasive study 
 
 
An invest igat ion of  intra-aort ic 
haemodynamics in aort ic dissect ion 
 
























Aortic dissection is a major cardiovascular emergency and the commonest aortic 
catastrophe. Management of this disease depends on the morphology of the dissection, in 
particular, whether it involves the ascending (Stanford Type A) or descending aorta (Stanford 
Type B) and the presence of complications such as rupture, rapid growth and end organ 
ischaemic events.  
Emergency surgery is the treatment of choice for Type A dissection although not every 
patient may be a candidate for surgery in view of pre-existing co-morbidities. Patients with 
Type B dissection are generally managed with strict pharmacological blood pressure control, 
although surgery is necessary in those with complications.  
Outcomes of patients with chronic, residual, non-surgically treated Type B dissection (as well 
as surgically repaired Type A with a residual Type B component) are variable with 1 in 4 
patients dead at 5 years from their original presentation. Predictors of outcomes are 
therefore needed to improve the prognosis in this population by identifying the at-risk group 
earlier.  
 
Rationale of the project 	  
The treatment of aortic dissection is largely dependent on the morphology of the dissection 
and the presence of complicating factors. Involvement of the ascending aorta (Type A) 
requires emergency surgery if co-morbidities allow. Patients with Type B dissection (not 
involving the ascending aorta) are usually managed conservatively, with blood pressure 
control. However, the presence of complicating factors such as end-organ ischaemia, rapid 
aortic growth, on-going pain or rupture, necessitate intervention with an endovascular device 
(stent-graft), to effectively seal the entry tear and promote thrombosis. Patients with repaired 
Type A dissection may still have a residual false lumen distally (residual Type B dissection) 
which may expand over time.  




Overall, stable patients are discharged with anti-hypertensives and require regular clinical 
review and imaging in the form of CT scans. These are performed to monitor overall aortic 
growth (defined as > 5mm growth between scans). An aorta that has a maximum diameter of 
5.5 cm will also require endovascular repair.  
Expansion of the false lumen is associated with adverse outcomes and false lumen 
haemodynamics may hold the answer to why some patients remain stable and others do not. 
A non-invasive method of determining these haemodynamic parameters would provide 
important insight into this complex disease and a greater understanding of how to best 
manage it. Non-invasive methods include using CT and MRI imaging and computational fluid 
dynamics (CFD) to estimate intra-aortic haemodynamics. However, these need to be 
validated against invasive methods that provide the ground truth.  One such invasive, gold 
standard method is pressure wire monitoring similar to that performed in the coronary 
vasculature to physiologically assess coronary lesions. 
Aim 	  
To determine invasive intra-aortic haemodynamics in patients with aortic dissection using 
pressure catheters.  
Experimental Design and Methods 
Introduction 	  
All patients who demonstrate rapid aortic growth (>5mm between clinical CT scans), or have 
a maximum aortic diameter of 5.5cm or have on-going symptoms or development of flow 
related complications are considered for endovascular repair. The stent graft procedure 
involves careful pre-planning between the vascular and interventional radiology teams to 
ensure appropriate device selection and access to the aorta. All endovascular procedures, 
by nature of being minimally invasive require fluoroscopic guidance.  




The research study will use a Certus PressureWire (St. Jude, MN, USA) which is a 
strengthened 0.014 inch wire with high-fidelity sensor technology which allows for 
simultaneous measurement of intravascular pressure, temperature and thermodilution 
(Figure 1). The presence of a hydrophilic coating enhances manoeuvrability and device 
compatibility. The sensor element of the wire is located 3 cm proximal to the tip and three 
electrical cables run from the sensor to the proximal end of the wire.  
Figure 1  
 
In conjunction with the Radianalyzer (St. Jude, MN, USA) monitor, accurate (+/-1 mmHg) 
readings of intravascular pressure can be made and recordings taken for further analysis 








Patient Identif ication 	  
All clinical patients are discussed at bi-weekly multi disciplinary meetings (MDTs) involving 
radiologists and vascular surgeons. Only those dissection patients who are identified as 
requiring an endovascular procedure in view of their increasing aortic dimensions or 
presence of symptoms are approached and consented for the operation by the vascular 
surgical team. All these patients are potential candidates for the research study if they are 
willing to participate.  
As this is a pilot study, no formal power calculation has been performed. It is estimated that 






Figure 2 A snapshot of the RadiAnalyzer monitor (A) and screen recordings during a TEVAR case (B) are 
shown. Red trace = aortic pressure, green trace= false lumen pressure. 
 





All adult patients (18-80y) with an aortic dissection that requires stent graft insertion to treat 
their dissection.  
Patient Exclusion 
Patient choice.  
Operators 
Consultant interventional radiologists and consultant surgeons. Supervised interventional 
radiology and surgical trainees. 
 Protocol 
a. Pre-procedure/ Information provision and consent 
Once a patient has been identified by the clinical team, they will be contacted to discuss the 
study. If they are at home, this will be by means of a patient information leaflet and telephone 
call. Admission for surgery is usually 3-4 days before the endovascular procedure and at this 
stage they will approached once again to confirm their interest in participating in the study. 
After a period of 24 hours to consider participation, written consent will be sought by a clinical 
member of the research team and recorded in the notes.  
b. Peri-operative 	  
On the day of the procedure, the patient will be prepared for theatre as is routine, by the ward 
and theatre staff. No special considerations need apply for the research study. All thoracic 
endovascular procedures usually take place in the hybrid theatre suites at St. Thomas’ 
Hospital. Figure 3 shows the expected set-up in the hybrid suite. During anaesthesia, the one 
of the co-investigators will arrange and set up all the required equipment that is needed to 
record the pressure wire data. Preoperative CT scans will be reviewed with the clinical team 




to determine the anatomical location from which readings will be taken to ensure efficient 
data collection. Once intravascular access has been achieved by means of usually an 8Fr 
sheath (via a femoral artery) a catheter is placed in the aorta around to the aortic valve. This 
is the same as would happen in the stent graft procedure. At this point a pressure wire 
catheter is opened, and passed to the operating team, in a sterile fashion. 
 
Calibration is then performed as per manufacturer’s instructions by placing the catheter flat 
on the sterile operating field and by pressing the calibrate button on the recording monitor. 
As part of the operative procedure a pigtail catheter is passed into the aorta to serve as a 
(fixed) reference catheter for the pressure measurements. Once this is done, a Y connector 










Figure 3 Set up in the hybrid theatre. With the C-arm in position, the RadiAnalyzer is attached to 
the operating table. Both the PressureWire (PW, green) and the pigtail (Ao, red) are connected to 
the transducer at the height of the patient’s right atrium. 




access for the pressure wire and the pig-tail aortic catheter, providing a reference reading for 
every intra-aortic pressure reading. 
Next, depending on the anatomical location into which the pressure wire is inserted (true or 
false lumen), pressure wire readings are acquired. The maximum time taken for these will be 
5 minutes.  
Once the readings are complete the wire is withdrawn and the stent graft procedure 
continues as per routine. It is estimated that the entire data collection part of the study will 
take no more than 5 minutes. 
 
List of equipment 	  
Pressure wire (St. Jude, MN, USA) 
Y-connector (Minvasys, France) 
Transducer (Edwards LifeSciences, CA) 
Heparinsed sodium chloride 1L, for transducer 
Pressure wire monitor (St. Jude, MN, USA) 
Connector tubing to connect to transducer 
 
Ethical considerations 
The pressure wire study is an invasive study that has a small but potential risk of stroke. We 
estimate this to be very small, probably less than an additional 0.1%. There is a very small 
risk of perforation of the aortic wall. It is important to consider that the patient is already 
undergoing a major invasive procedure with an inherent risk of aortic rupture. Overall the risk 
of rupture from the pressure wire is thought to be less than 0.5% and the treatment involves 




sealing the rupture with a stent graft. The endovascular procedure requires ionising radiation 
and the pressure wire study will add an estimated maximum of 5 minutes, pulsed radiation.  
 
Benefits of the study 
It is unlikely that patients undergoing this procedure will benefit directly from this study but 
information collected here will be used to develop accurate non-invasive methods of vascular 
haemodynamic assessment, which future patients will benefit from.  
 
Resources and costs 
1x Pressure wire £350 
1x Transducer £ 10.20 
1x Y Connector £19.50 
1x Radiview monitor free of charge 




________________     __________ 
Chief investigator          Date 
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Aortic dissection is a major cardiovascular emergency and the commonest aortic 
catastrophe. Management of this disease depends on the morphology of the dissection, in 
particular, whether it involves the ascending (Stanford Type A) or descending aorta (Stanford 
Type B) and the presence of complications such as rupture, rapid growth and end organ 
ischaemic events.  
Emergency surgery is the treatment of choice for Type A dissection although not every 
patient may be a candidate for surgery in view of pre-existing co-morbidities. Patients with 
Type B dissection are generally managed with strict pharmacological blood pressure control, 
although surgery is necessary in those with complications.  
Outcomes of patients with chronic, residual, non-surgically treated Type B dissection (as well 
as surgically repaired Type A with a residual Type B component) are variable with more than 
1 in 4 patients dead at 5 years from their original presentation. Predictors of outcomes are 
therefore needed to improve the prognosis in this population by identifying the at-risk group 
earlier.  
Rationale of the project 
 
The treatment of aortic dissection is largely dependent on the morphology of the dissection 
and the presence of complicating factors. Involvement of the ascending aorta (Type A) 
requires emergency surgery if co-morbidities allow. Patients with Type B dissection (not 
involving the ascending aorta) are usually managed conservatively, with blood pressure 
control. The presence of complicating factors however, (end-organ ischaemia, rapid aortic 
growth, on-going pain or rupture) necessitate intervention with an endovascular device 
(stent-graft), to effectively seal the entry tear and promote thrombosis. Patients with repaired 
Type A dissection may still have a residual false lumen distally (residual Type B dissection) 
which may expand over time.  




Overall, stable patients are discharged with anti-hypertensives and require regular clinical 
review and imaging in the form of CT scans. These are performed to monitor overall aortic 
growth (defined as > 5mm growth between scans). An aorta that has a maximum diameter of 
5.5 cm will also require endovascular repair.  
Expansion of the false lumen is associated with adverse outcomes and false lumen 
haemodynamics may hold the answer to why some patients remain stable and others do not. 
A non-invasive method of determining these haemodynamic parameters will provide 
important insight into this complex disease and a greater understanding of how to best 
manage it. Non-invasive methods include using CT and MR imaging and computational fluid 
dynamics (CFD) to estimate intra-aortic haemodynamics.  
Aims 
 
To develop a non-invasive method for assessing intra-aortic haemodynamics in patients with 
aortic dissection using CT and MR imaging and Computational Fluid Dynamics (CFD) 
simulation. 
Experimental Design and Methods 
Introduction 
 
All patients who present with aortic dissection who are considered to be stable are 
discharged home with stringent blood pressure control, and return for regular follow up CT 
scans. These patients will be invited for a maximum of 3 MR scans (if not already clinically 
performed).  
 




Patient Identif ication 
 
All clinical patients are discussed at bi-weekly multi disciplinary meetings (MDTs) involving 
radiologists and vascular surgeons. As this is a pilot study, no formal power calculation has 
been performed. It is estimated that data will be collected from a maximum of 15 patients.  
Patient Inclusion 
 




Patient choice and contra-indications to MR imaging, listed below. 
Risks and burdens 
 
MR imaging does not have any known adverse effects. There are well-established 
contraindications for MR imaging, including pacemakers and other implanted metallic 
devices or metallic foreign bodies. Procedures in place in the MR unit will be used in this 
study to screen for and exclude such subjects. 
A small proportion of people (<5%) experience claustrophobia on entering an MR scanner. It 
will be made clear to patients that they can terminate the study at any time if they are 
affected. No other discomfort or distress should be caused. 
Gadolinium MR contrast agents can potentially cause allergic reactions although severe 
reactions are very rare. Administration of these agents is considered to be safe in patients 
without severe impairment of renal function.  
Patients with acute or chronic severe renal impairment (i.e, GFR <30mL/min/1·73m2) will be 
excluded. In accordance with current recommendations we will screen all patients for renal 
dysfunction by checking the most recent blood tests on the hospital system or via the GP. 






Once a patient has been identified by the clinical team, they will be contacted by the 
research team to discuss participation in the study. If they are at home, this will be by means 
of a patient information leaflet and telephone call. Patients who are considered stable and 
nearing discharge will be approached on the wards.  
All MR scans will take place at the King’s College 3T scanner Research scanner based at St. 
Thomas’ hospital using standard clinical protocols.  
A contrast agent will be required to enhance the images to improve anatomical detail and 
quantification of flow and false lumen thrombosis. Commonly used agents are either 
Gadovist (standard agent) or Vasovist (blood pool agent). 
Monitoring and safety 
 
During the entire examination the patients will be monitored closely. All serious adverse 
event (SAE), serious adverse reaction (SAR) or unexpected adverse reaction (UAR) will be 
reported immediately by the Chief Investigator to King’s College London (sponsor). As 
appropriate, these will then reported to the regulatory authorities. This research is associated 
with the NHS indemnity scheme. 
Confidentiali ty 
 
Person-identifiable image data may be stored on the MRI scanner. Data and image data will 
be identified by anonymous study number when transferred to computers for further analysis. 
Only the trial investigators will have access to the linkage between study number to patient 
identity. Data used for dissemination of results by presentation or publication will be 
anonymous.  




Ethics and Regulatory Approval 
 
Application for ethical approval has been made in conjunction with this document. 
Quality assurance, data handling, publication policy & finance 
 
Quality assurance will be maintained by Trust Clinical and Research Governance. Data 
protection will be maintained according to Trust guidelines. The Data Protection Act 1998 will 
be complied with. All information collected during the course of the study will be kept strictly 
confidential. Information will be held securely electronically with encryption of any transfer 
data.  
Benefits to participants  
 
It is unlikely that patients undergoing this procedure will benefit directly from this study but 
information collected here will be used to develop accurate non-invasive methods of vascular 
haemodynamic assessment, which future patients will benefit from.  
Resources and costs 
 
1x MRI scan £300 
1x contrast agent £50 








A4 Consent form- invasive study 
 
Centre Number:  
Study Number: 14/LO/0286 
Patient Identification Number for this trial: 
Version: 1 








Name of Researcher: Alia Noorani   Please initial box             
 
1. I confirm that I have read and understand the information sheet dated ............................   
(version 2 for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
                                                                                                                              
  
2. I understand there is a risk of a tear in the aorta approximately less than 0.5% and that the 
treatment for this will be the same as my planned stent graft procedure                                   
            
 
 
                              
3. I understand that there is a very small risk of stroke (0.1%).                                     
            
   
 
4. I understand that my participation is voluntary and that I am free to withdraw at anytime, 
without giving any reason, without my medical care or legal rights being affected.                                                             
                                                              
                             
 
5. I understand that relevant sections of any of my medical notes and data collected during 
the study may be looked at by responsible individuals from King’s College London, from 
regulatory authorities or from the NHS Trust, where it is relevant to my taking part in this 
research.  I give permission for these individuals to have access to my records.                            
  
                          
                                     
  
6. I agree to my GP being informed of my participation in the study.                           
                                  
 
7. I agree to take part in the above study.                                           








________________________ ________________ _______ 




_________________________ ________________  
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 

















































Study Number: 14/LO/0286 
Patient Identification Number for this trial: 
Version:2 








Name of Researcher: Alia Noorani   Please initial box  
 
 
1. I confirm that I have read and understood the information sheet dated ............................ 
(version 2) for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
                                                                                                                                                                                                                                                    
 
2. I understand there is a risk of an allergic reaction to the contrast agent used in the MRI 
scan (mild approx.1%, severe <0.00001%) and nephrogenic systemic fibrosis (NSF) in 
severe renal impairment (<1%) 
                                                  	  
	  
 
3.  I understand that I may feel claustrophobic (<5%) and that if I have metal fillings in my 
teeth I may feel tingling during the scan (<1%).                       
                                 
                                                                                                                            
                                
4. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected.        
                                        




   	   	    
5. I understand that relevant sections of any of my medical notes and data collected during 
the study may be looked at by responsible individuals from King’s College London, from 
regulatory authorities or from the NHS Trust, where it is relevant to my taking part in this 
research.  I give permission for these individuals to have access to my records.                 
                                                      
                  
                                                                                                                                                                                   
   
6. I agree to my GP being informed of my participation in the study.              
                           	  
 










Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
_________________________ _________________________  
Researcher   Date  Signature 
 
 
 
 
	  
 
